Chicago Authored WIHS Publications

Chicago Authored WIHS Publications: 562 as of November 2017

2017 Publications (48)

562 Burke-Miller JK, Weber KM, Cohn SE, Hershow RC, Sha B, French AL, Cohen MH. Measurement of Neighborhood Context in an Urban Cohort of HIV-Infected or at Risk Low-Income Women. Journal of Poverty 2017; 21(1):80-96.
561 Adams LM, Wilson TE, Merenstein D, Milam J, Cohen J, Golub ET, Adedimeji A, Cook JA. Using the Center for Epidemiologic Studies Depression Scale to Assess Depression in Women With HIV and Women at Risk for HIV: Are Somatic Items Invariant? Psychol Assess 2017 Feb 23. [Epub ahead of print] PMC5568988
560 Ascher SB, Scherzer R, Peralta CA, Tien PC, Grunfeld C, Estrella MM, Abraham A, Gustafson DR, Nowicki M, Sharma A, Cohen MH, Butch AW, Young MA, Bennett MR, Shlipak MG. Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women. Hypertension 2017 Feb;69(2):304-313. Epub 2016 Dec 19. PMC5233560
559 Baxi SM, Greenblatt RM, Bacchetti P, Cohen M, DeHovitz JA, Anastos K, Gange SJ, Young MA, Aouizerat BE. Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV. Pharmacogenomics J 2017 May 2. [Epub ahead of print] PMC Journal-In Process
558 Baxi SM, Scherzer R, Jotwani V, Estrella MM, Abraham AG, Parikh CR, Bennett MR, Cohen MH, Nowicki MJ, Gustafson DR, Sharma A, Young MA, Shlipak MG; Women’s Interagency HIV Study (WIHS). Changes in Urinary Biomarkers over 10 Years is Associated with Viral Suppression in a Prospective Cohort of Women Living with HIV. J Acquir Immune Defic Syndr 2017 Apr 15;74(5):e138-e145. PMC5340602
557 Butterfield TR, Hanna DB, Kaplan RC, Kizer JR, Durkin HG, Young MA, Nowicki MJ, Tien PC, Golub ET, Floris-Moore MA, Titanji K, Fischl MA, Heath SL, Martinson J, Crowe SM, Palmer CS, Landay AL, Anzinger JJ. Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV- infected women with subclinical cardiovascular disease. AIDS 2017 Jan 14;31(2):199-205. PMC5393043
556 Byambaa E, Erdembileg A, Zhang W, Li CS, Kaplan R, Lazar J, Merenstein D, Karim R, Aouizerat B, Cohen M, Butler K, Pahwa S, Ofotokun I, Adimora AA, Golub E, Berglund L. Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women’s Interagency HIV Study. Arterioscler Thromb Vasc Biol 2017 May;37(5):997-1004. Epub 2017 Mar 23. PMC5408307
555 Dale S, Weber K, Cohen M, Brody L. Abuse, nocturnal stress hormones, and coronary heart disease risk among women with HIV. AIDS Care 2017 May;29(5):598-602. Epub 2016 Oct 13. PMC Journal-In Process
554 Dapp MJ, Kober KM, Chen L, Westfall DH, Wong K, Zhao H, Hall BM, Deng W, Sibley T, Ghorai S, Kim K, Chen N, McHugh S, Au L, Cohen M, Anastos K, Mullins JI. Patterns and rates of viral evolution in HIV-1 subtype B infected females and males. PLoS One 2017 Oct 18;12(10):e0182443. PMC5646779
553 Dubrow R, Qin L, Lin H, Hernández-Ramírez RU, Neugebauer RS, Leyden W, Althoff KN, Achenbach CJ, Hessol NA, Modur SP, D’Souza G, Bosch RJ, Grover S, Horberg MA, Kitahata MM, Mayor AM, Novak RM, Rabkin CS, Sterling TR, Goedert JJ, Justice AC, Engels EA, Moore RD, Silverberg MJ; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada. J Acquir Immune Defic Syndr 2017 Aug 1;75(4):382-390. PMC5490794
552 Edmonds A, Ludema C, Eron JJ Jr, Cole SR, Adedimeji AA, Cohen MH, Cooper HL, Fischl M, Johnson MO, Krause DD, Merenstein D, Milam J, Wilson TE, Adimora AA. Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV. J Womens Health (Larchmt) 2017 Jul 6. [Epub ahead of print] PMC Journal-In Process
551 Enkhmaa B, Anuurad E, Zhang W, Li CS, Kaplan R, Lazar J, Merenstein D, Karim R, Aouizerat B, Cohen M, Butler K, Pahwa S, Ofotokun I, Adimora AA, Golub E, Berglund L. Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women’s Interagency HIV Study. Arterioscler Thromb Vasc Biol 2017

May;37(5):997-1004. Epub 2017 Mar 23. PMC5408307

550 French AL, Martin JW, Evans CT, Peters M, Kessaye SG, Nowicki M, Kuniholm M, Golub E, Augenbraun M, Desai SN; WIHS. Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2017 Dec 1;76(4):438-444. PMC5679288
549 Gustafson DR, Shi Q, Holman S, Minkoff H, Cohen MH, Plankey MW, Havlik R, Sharma A, Gange S, Gandhi M, Milam J, Hoover DR. Predicting death over 8 years in a prospective cohort of HIV- infected women: the Women’s Interagency HIV Study. BMJ Open 2017 Jun 30;7(6):e013993. PMC5577878
548 Haddad LB, Wall KM, Mehta CC, Golub ET, Rahangdale L, Kempf MC, Karim R, Wright R, Minkoff H, Cohen M, Kassaye S, Cohan D, Ofotokun I, Cohn SE. Trends of and factors associated with live- birth and abortion rates among HIV-positive and HIV-negative women. Am J Obstet Gynecol 2017

Jan;216(1):71.e1-71.e16. Epub 2016 Sep 15. PMC5182149

547 Hanna DB, Lin J, Post WS, Hodis HN, Xue X, Anastos K, Cohen MH, Gange SJ, Haberlen SA, Heath SL, Lazar JM, Liu C, Mack WJ, Ofotokun I, Palella FJ, Tien PC, Witt MD, Landay AL, Kingsley LA, Tracy RP, Kaplan RC. Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men. J Infect Dis 2017 May

1;215(9):1352-1361. PMC Journal-In Process

546 Hotton AL, Weber KM, Hershow RC, Anastos K, Bacchetti P, Golub ET, Gustafson D, Levine AM, Young M, Cohen MH. Prevalence and Predictors of Hospitalizations Among HIV-Infected and At- Risk HIV-Uninfected Women. J Acquir Immune Defic Syndr 2017 Jun 1;75(2):e27-e35. PMC5429173
545 Imp BM, Rubin LH, Tien PC, Plankey MW, Golub ET, French AL, Valcour VG. Monocyte Activation is Associated with Worse Cognitive Performance in Virologically Suppressed HIV-Infected Women. J Infect Dis 2017 Jan 1;215(1):114-121. Epub 2016 Oct 26. PMC5225255
544 Jacobs ES, Keating SM, Abdel-Mohsen M, Gibb SL, Heitman JW, Inglis HC, Martin JN, Zhang J, Kaidarova Z, Deng X, Wu S, Anastos K, Crystal H, Villacres MC, Young M, Greenblatt RM, Landay AL, Gange SJ, Deeks SG, Golub ET, Pillai SK, Norris PJ; Women’s Interagency HIV Study. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication in vitro and Modulate HIV Restriction Factor Expression. J Virol 2017 Feb 28;91(6). Print 2017 Mar 15. PMC5331794
543 Keating SM, Dodge JL, Norris PJ, Heitman J, Gange SJ, French AL, Glesby MJ, Edlin BR, Latham PS, Villacres MC, Greenblatt RM, Peters MG; Women’s Interagency HIV Study. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women’s Interagency HIV Study. PLoS One 2017 Sep 13;12(9):e0181004. PMC5597129
542 Kelso-Chichetto NE, Okafor CN, Cook RL, Abraham AG, Bolan R, Plankey M. Association between depressive symptom patterns and clinical profiles among persons living with HIV. AIDS Behav

2017 Jun 7. [Epub ahead of print] PMC Journal-In Process

541 Kelso-Chichetto NE, Plankey M, Abraham AG, Ennis N, Chen X, Bolan R, Cook RL. Association between alcohol consumption trajectories and clinical profiles among women and men living with HIV. Am J Drug Alcohol Abuse 2017 Jun 16:1-10. [Epub ahead of print] PMC Journal-In Process
540 Kelso-Chichetto NE, Plankey M, Sheps DS, Abraham AG, Chen X, Shoptaw S, Kaplan RC, Post WS, Cook RL. The impact of long-term moderate and heavy alcohol consumption on incident atherosclerosis among persons living with HIV. Drug Alcohol Depend 2017 Dec 1;181:235-241. Epub 2017 Oct 28.  PMC Journal-In Process
539 Kuniholm MH, Liang H, Anastos K, Gustafson D, Kassaye S, Nowicki M, Sha BE, Pawlowski EJ, Gange SJ, Aouizerat BE, Pushkarsky T, Bukrinsky MI, Prasad VR. Association of a 3′ Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co- Infected Women. AIDS 2017 Sep 18. [Epub ahead of print] PMC Journal-In Process
538 Ludema C, Cole SR, Eron JJ Jr, Holmes GM, Anastos K, Cocohoba J, Cohen MH, Cooper HL, Golub ET, Kassaye S, Konkle-Parker D, Metsch L, Milam J, Wilson TE, Adimora AA. Health Insurance Type and Control of Hypertension Among US Women Living With and Without HIV Infection in the Women’s Interagency HIV Study. Am J Hypertens 2017 Jun 1;30(6):594-601. PMC Journal-In Process
537 Massad LS, Hessol NA, Darragh TM, Minkoff H, Colie C, Wright RL, Cohen M, Seaberg EC. Cervical cancer incidence after up to 20 years of observation among women with HIV. Int J Cancer 2017

Oct 15;141(8):1561-1565. Epub 2017 Jul 17.  PMC Journal-In Process

536 Massad LS, Evans CT, Kang R, Hotton A, Greenblatt R, Minkoff H, Murphy K, Colie C, Weber KM. Correlates of Bacterial Vaginosis Over Long-Term Follow-Up: Impact of HIV Infection. AIDS Res Hum Retroviruses 2017 May;33(5):432-439. Epub 2016 Dec 16. PMC5439437
535 Mistretta EG, Sloan D, BrintzenhofeSzoc K, Weber KM, Berger A. Testing domains of the healing experiences in all life stressors questionnaire in a cohort of HIV-infected and HIV-uninfected Chicago women. Psychol Res Behav Manag 2017 Jul 4;10:201-208. PMC5505676
534 Nabi R, Moldoveanu Z, Wei Q, Golub ET, Durkin HG, Greenblatt RM, Herold BC, Nowicki MJ, Kassaye S, Cho MW, Pinter A, Landay AL, Mestecky J, Kozlowski PA. Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy. PLoS One 2017 Jul 3;12(7):e0180245. PMC5495342
533 Park SY, Love TMT, Reynell L, Yu C, Kang TM, Anastos K, DeHovitz J, Liu C, Kober KM, Cohen M, Mack WJ, Lee HY. The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards. Sci Rep 2017 Aug 7;7(1):7480. PMC5547093
532 Reid M, Ma Y, Scherzer R, Price J, French AL, Plankey MW, Grunfeld C, Tien PC. Higher CD163 levels is associated with insulin resistance in HCV and HIV-infected adults. AIDS 2017 Jan

28;31(3):385-393. PMC5235318

531 Reid MJA, Baxi SM, Sheira LA, Landay AL, Frongillo EA, Adedimeji A, Cohen MH, Wentz E, Gustafson DR, Merenstein D, Hunt PW, Tien PC, Weiser SD; Womenʼs Interagency HIV Study (WIHS). Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV. J Acquir Immune Defic Syndr 2017 Aug 15;75(5):e132- e141. PMC5503764
530 Robbins HA, Strickler HD, Massad LS, Pierce CB, Darragh TM, Minkoff H, Keller MJ, Fischl M, Palefsky J, Flowers L, Rahangdale L, Milam J, Shrestha S, Colie C, DʼSouza G. Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach. AIDS 2017 Apr 24;31(7):1035-1044. PMC5531443
529 Rubin LH, Cook JA, Springer G, Weber KM, Cohen MH, Martin EM, Valcour VG, Benning L, Alden C, Milam J, Anastos K, Young MA, Gustafson DR, Sundermann EE, Maki PM. Perceived and post- traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women. AIDS 2017 Aug 28. [Epub ahead of print] PMC Journal-In Process
528 Rubin LH, Maki PM, Springer G, Benning L, Anastos K, Gustafson D, Villacres MC, Jiang X, Adimora AA, Waldrop-Valverde D, Vance DE, Bolivar H, Alden C, Martin EM, Valcour VG; Women’s Interagency HIV Study. Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression. Neurology 2017 Oct 10;89(15):1594-1603. Epub 2017 Sep 13. PMC5634661
527 Rubin LH, Benning L, Keating SM, Norris PJ, Burke-Miller J, Savarese A, Kumanan KN, Awadalla S, Springer G, Anastos K, Young M, Milam J, Valcour VG, Weber KM, Maki PM. Variability in C- reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study. J Neurovirol 2017 Oct 23. [Epub ahead of print] PMC Journal-In Process
526 Sarkar M, Dodge JL, Greenblatt RM, Kuniholm MH, DeHovitz J, Plankey M, Kovacs A, French AL, Seaberg EC, Ofotokun I, Fischl M, Overton E, Kelly E, Bacchetti P, Peters MG; Women’s Interagency HIV Study. Reproductive Aging and Hepatic Fibrosis Progression in HIV/Hepatitis C Virus Co-Infected Women. Clin Infect Dis 2017 Oct 30;65(10):1695-1702. PMC Journal-In Process
525 Scherzer R, Greenblatt RM, Merhi ZO, Kassaye S, Lambert-Messerlian G, Maki PM, Murphy K, Karim R, Bacchetti P. Use of antimüllerian hormone to predict the menopausal transition in HIV- infected women. Am J Obstet Gynecol 2017 Jan;216(1):46.e1-46.e11. Epub 2016 Jul 26. PMC5182170.
524 Sharma A, Hoover DR, Shi Q,  Tsao JCI, Cox C, Gustafson DR, Weber K, Greenblatt RM, Aouizerat BE, Plankey MW. Frequent Occurrence of Pain and Prescription Opioid Use for Treatment of Pain among Women with and at Risk for HIV Infection. AIDS and Behavior 2017 Jun 19. [Epub ahead of print] PMC Journal-In Process NIHMSID 886268
523 Sharma A, Hoover DR, Shi Q, Holman S, Plankey MW, Tien PC, Weber KM, Floris-Moore M, Bolivar HH, Vance DE, Golub ET, Holstad MM, Yin MT. Longitudinal Study of Falls among HIV-infected and Uninfected Women: the Role of Cognition. Antivir Ther 2017 Sep 21. [Epub ahead of print] PMC Journal-In Process
522 Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D’Souza G, Dubrow R, Eron JJ, Gebo K, Gill MJ, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. HIV Infection, Immune Suppression and Age at Diagnosis of Non-AIDS-Defining Cancers. Clin Infect Dis 2017 Feb 15;64(4):468-475. PMC Journal-In Process
521 Todd JV, Cole SR, Pence BW, Lesko CR, Bacchetti P, Cohen MH, Feaster DJ, Gange S, Griswold ME, Mack W, Rubtsova A, Wang C, Weedon J, Anastos K, Adimora AA. Effects of Antiretroviral Therapy and Depressive Symptoms on All-Cause Mortality Among HIV-Infected Women. Am J Epidemiol

2017 May 15;185(10):869-878. PMC5430940

520 Todd JV, Cole SR, Wohl DA, Simpson RJ Jr, Jonsson Funk M, Brookhart MA, Cocohoba J, Merenstein D, Sharma A, Lazar J, Milam J, Cohen M, Gange S, Lewis TT, Burkholder G, Adimora AA. Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women. AIDS Patient Care STDS 2017 Nov;31(11):447-454. PMC5665094
519 Turan B, Rogers AJ, Rice WS, Atkins GC, Cohen MH, Wilson TE, Adimora AA, Merenstein D,

Adedimeji A, Wentz EL, Ofotokun I, Metsch L, Tien PC, Johnson MO, Turan JM, Weiser SD. Association between Perceived Discrimination in Healthcare Settings and HIV Medication Adherence: Mediating Psychosocial Mechanisms. AIDS Behav 2017 Oct 28. [Epub ahead of print] PMC Journal-In Process

518 Vergara C, Thio C, Latanich R, Cox AL, Kirk GD, Mehta SH, Busch M, Murphy EL, Villacres MC, Peters MG, French AL, Golub E, Eron J, Lahiri CD, Shrestha S, Gustafson D, Young M, Anastos K, Aouizerat B, Kim AY, Lauer G, Thomas DL, Duggal P. Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun Genes 2017 Mar;18(2):82-87. Epub 2017 Mar 16. PMC5408324
517 Westreich D, Cates J, Cohen M, Weber KM, Seidman D, Cropsey K, Wright R, Milam J, Young MA, Mehta CC, Gustafson DR, Golub E, Fischl MA, Adimora AA. Smoking, HIV, and risk of pregnancy loss. AIDS 2017 Feb 20;31(4):553-560. PMC5263172
516 Wilson TE, Weedon J, Cohen MH, Golub ET, Milam J, Young MA, Adedimeji AA, Cohen J, Fredrickson BL. Positive affect and its association with viral control among women with HIV infection. Health Psychol 2017 Jan;36(1):91-100. Epub 2016 Sep 29. PMC5209281
515 Zhang Y, Wilson TE, Adedimeji A, Merenstein D, Milam J, Cohen J, Cohen M, Golub ET. The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States. AIDS Behav 2017 May 30. [Epub ahead of print] PMC Journal-In Process

2016 Publications (38)

514 Baxi S, Scherzer R, Greenblatt R, Minkoff H, Sharma A, Cohen M, Young M, Abraham A, Shlipak M. Higher Tenofovir Exposure is Associated with Longitudinal Declines in Kidney Function in Women Living with HIV. AIDS 2016 Feb;30(4):609-618. PMC4782771
513 Brody LR, Jack DC, Bruck-Segal DL, Ruffing EG, Firpo-Perretti YM, Dale SK, Weber KM, Cohen MH. Life Lessons from Women with HIV: Mutuality, Self-Awareness, and Self-Efficacy. AIDS Patient Care STDS 2016 Jun;30(6):261-73. Epub 2016 May 23. PMC4913488
512 Burke-Miller JK, Weber K, Cohn SE, Hershow RC, Sha BE, French AL, Cohen MH. Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV. AIDS Care 2016 Oct;28(10):1274-9. Epub 2016 Apr 21. PMC5049499
511 Decker M, Benning L, Weber K, Sherman S, Adedimeji A, Wilson T, Cohen J, Plankey M, Cohen M, Golub E. Physical and Sexual Violence Predictors: 20 Years of the Women’s Interagency HIV Study Cohort. Am J Prev Med 2016 Nov;51(5):731-742. Epub 2016 Aug 29. PMC5360180
510 Cook RL, Cook CL, Karki M, Weber KM, Thoma KA, Loy CM, Goparaju L, Rahim-Williams B. Perceived benefits and negative consequences of alcohol consumption in women living with HIV: a qualitative study. BMC Public Health 2016 Mar;16(1):263. PMC4791930
509 Desai SN, Dodge JL, Landay AL, Glesby MJ, Latham PS, Villacres MC, French AL, Gange SJ, Greenblatt RM, Peters MG. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women’s interagency HIV study. Medicine (Baltimore) 2016 Aug;95(33). PMC5370796
508 Gustafson DR, Shi Q, Thurn M, Holman SA, Minkoff H, Cohen M, Plankey MW, Havlik R, Sharma A, Gange S, Gandhi M, Milam J, Hoover D. Frailty and Constellations of Factors in Aging HIV-Infected and Uninfected Women – The Women’s Interagency HIV Study. J Frailty Aging 2016 Mar;5(1):43-48. PMC4957016
507 Hanna DB, Jung M, Xue X, Anastos K, Cocohoba JM, Cohen MH, Golub ET, Hessol NA, Levine AM, Wilson TE, Young MA, Kaplan RC. Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women’s Interagency HIV Study and Association with Adherence to Antiretroviral Therapy. AIDS Patient Care STDS 2016 Oct;30(10):445-454. PMC5069716
506 Hessol NA, Holman S, Minkoff H, Cohen M, Golub E, Kassaye S, Karim R, Sosanya K, Shaheen C, Merhi Z. Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV. AIDS Care 2016 Jan;28(1):11-21. Epub 2015 Aug. PMC4713239
505 Hu X, Harman J, Winterstein AG, Zhong Y, Wheeler AL, Taylor TN, Plankey M, Rubtsova A, Cropsey K, Cohen MH, Adimora AA, Milam J, Adedimeji A, Cook RL. Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous Drinking. J Subst Abuse Treat 2016 May;64:55-61. Epub 2016 Feb 15. PMC4943324
504 Kelly EM, Dodge JL, Sarkar M, French AL, Tien PC, Glesby MJ, Golub ET, Augenbraun M, Plankey M, Peters MG. Marijuana Use is not Associated with Progression to Advanced Liver Fibrosis in HIV/HCV Coinfected Women. Clin Infect Dis 2016 Aug 15;63(4):512-8. Epub 2016 May 25. PMC4967608
503 Kerzerho J, McIlvaine EJ, Anthony P, Mack WJ, Wang CH, Frederick T, Operskalski E, Chen Z, Al- Harthi L, Landay A, Young MA, Tien PC, Augenbraun M, Strickler HD, Akbari O, Golub ET, Sharp GB, Kovacs A. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women. J Acquir Immune Defic Syndr 2016 Feb;71(2):172-180. PMC4712709
502 Kuniholm MH, OʼBrien TR, Prokunina-Olsson L, Augenbraun M, Plankey M, Karim R, Sarkar M, French AL, Pierce C, Strickler HD, Anastos K. Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women. J Acquir Immune Defic Syndr 2016 Jun 1;72(2):162-70. PMC4874499
501 Kuniholm MH, Xie X, Anastos K, Xue X, Reimers L, French AL, Gange SJ, Kassaye SG, Kovacs A, Wang T, Aouizerat BE, Strickler HD. Human leucocyte antigen class I and II imputation in a multiracial population. Int J Immunogenet 2016 Dec;43(6):369-375. Epub 2016 Oct 24. PMC5118156
500 Lam JO, Bream JH, Sugar EA, Coles CL, Weber KM, Burk RD, Wiley DJ, Cranston RD, Reddy S, Margolick JB, Strickler HD, Wentz A, Jacobson L, Guo Y, Xiao W, Gillison ML, D’Souza G. Association of serum cytokines with oral HPV clearance. Cytokine 2016 Jul;83:85-91. Epub 2016 Apr 8. PMC4875862
499 Lam JO, Sugar EA, Cranston RD, Weber KM, Burk RD, Wiley DJ, Reddy S, Margolick JB, Strickler HD, Wentz A, Jacobson L, Coles CL, Bream JH, Rositch AF, Guo Y, Xiao W, Gillison ML, D’Souza G. The association of medication use with clearance or persistence of oral HPV infection. Cancer Causes Control 2016 Dec;27(12):1491-1498. Epub 2016 Nov 1. PMC5282943
498 Ludema C, Cole SR, Eron JJ, Edmonds AE, Holmes MG, Anastos K, Cochohoba J, Cohen MH, Cooper H, Golub ET , Kassaye S, Konkle-Parker D, Metsch L, Milman J, Wilson TE, Adimora AA. Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women’s Interagency HIV Study, 2006-2009. J Acquir Immune Defic Syndr 2016 Nov 1;73(3):307-312. PMC5089078
497 Lurain NS, Hanson BA, Hotton A, Weber KM, Cohen M, Landay A. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1 Infected Women. AIDS Res Hum Retroviruses 2016 Feb;32(2):134-143. Epub 2015 Oct 22. PMC4761818
496 Massad LS, Xie X, Burk RD, D’Souza G, Darragh TM, Minkoff H, Colie C, Burian P, Palefsky J, Atrio J, Strickler HD. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women. Am J Obstet Gynecol 2016 Mar;214(3):354. Epub 2015 Nov 14. PMC4775397
495 Massad L, Keller M, Xie X, Minkoff H, Palefsky J, DʼSouza G, Colie C, Villacres M, Strickler H. Multitype Infections With Human Papillomavirus: Impact of Human Immunodeficiency Virus Coinfection. Sex Transm Dis 2016 Oct;43(10):637-41. PMC5026395
494 Norris PJ, Zhang J, Worlock A, Nair SV, Anastos K, Minkoff HL, Villacres MC, Young M, Greenblatt RM, Desai S, Landay AL, Gange SJ, Nugent CT, Golub ET, Keating SM. Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection. Open Forum Infect Dis 2016 Feb 8;3(1). PMC4782066
493 Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W. Enhanced liver fibrosis marker as a non-invasive predictor of mortality in HIV/HCV-coinfected women from thewomen’s Interagency HIV study. AIDS 2016 Mar;30(5):723-729. PMC4802865
492 Reimers L, Mehta S, Massad S, Burk R, Xie X, Ravel J, Cohen M, Palefsky J, Weber K, Xue X, Anastos K, Minkoff H, Atrio J, D’Souza G, Ye Q, Colie C, Zolnik C,  Spear G, Strickler H. The Cervicovaginal Microbiota and Its Associations with Human Papillomavirus (HPV) Detection in HIV-Infected and HIV-Uninfected Women. J Infect Dis 2016 Aug 11. PMC5079369
491 Rubin LH, Wu M, Sundermann EE, Meyer VJ, Smith R, Weber KM, Cohen MH, Little DM, Maki PM. Elevated stress is associated with prefrontal cortex dysfunction during a verbal memory task in women with HIV. J Neurovirol 2016 Apr 19. PMC5071112
490 Rubin LH, Pyra M, Cook JA, Weber KM, Cohen MH, Martin E, Valcour V, Milam J, Anastos K, Young MA, Alden C, Gustafson DR, Maki PM. Post-traumatic stress is associated with verbal learning, memory, and psychomotor speed in HIV-infected and HIV-uninfected women. J Neurovirol 2016Apr;22(2):159-169. Epub 2015 Sep 24. PMC4783199
489 Scherzer R, Lin H, Abraham A, Thiessen-Philbrook H, Parikh CR, Bennett M, Cohen MH, Nowicki M, Gustafson DR, Sharma A, Young M, Tien P, Jotwani V, Shlipak MG. Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women. Nephrol Dial Transplant 2016 Sep;31(9):1478-85. Epub 2016 Jan 10. PMC5009288
488 Seang S, Lake JE, Tian F, Anastos K, Cohen MH, Tien PC. Oral Glucose Tolerance Testing identifies HIV+ infected women with Diabetes Mellitus (DM) not captured by standard DM definition. J AIDS Clin Res 2016 Feb;7(2). Epub 2016 Feb 20. PMC4825684
487 Sharma A, Ma Y, Scherzer R, Wheeler AL, Cohen M, Gustafson DR, Keating SM, Yin MT, Tien PC. Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV- Uninfected Women. J Acquir Immune Defic Syndr 2016 Dec 1;73(4):433-437. PMC5098807
486 Sharma A, Hoover DR, Shi Q, Holman S, Plankey MW, Wheler AL, Weber K, Floris-Moore M, Bolivar HH, Vance DE, Mack Wj, Golub ET, Holstad MM, Yin MT. Falls among middle-aged women in the Women’s Interagency HIV Study. Antivir Ther 2016;21(8):697-706. Epub 2016 Jul 18. PMC5243157
485 Spencer LY, Christiansen S, Wang CH, Mack WJ, Young M, Strickler HD, Anastos K, Minkoff H, Cohen M, Greenblatt RM, Karim R, Operskalski E, Frederick T, Homans JD, Landay A, Kovacs A. Systemic Immune Activation and HIV Shedding in the Female Genital Tract. J Acquir Immune Defic Syndr 2016 Feb;71(2):155-162. PMC4712091
484 Swanson S, Ma Y, Scherzer R, Huhn G, French AL, Plankey MW, Grunfeld C, Rosenberg WM, Peters MG, Tien PC. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score. J Infect Dis 2016 Apr 1;213(7):1079-86. PMC4779303
483 Taylor TN, Munoz-Plaza CE, Goparaju L, Martinez O, Holman S, Minkoff HL, Karpiak SE, Gandhi M, Cohen MH, Golub ET, Levine AM, Adedimeji AA, Gonsalves R, Bryan T, Connors N, Schechter G, Wilson TE. “The Pleasure Is Better as I’ve Gotten Older”: Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV. Arch Sex Behav 2016 May 24. PMC5122465
482 Todd JV, Cole SR, Pence BW, Lesko CR, Bacchetti P, Cohen MH, Feaster DJ, Gange S, Griswold M, Mack W, Rubtsova A, Wang C, Weedon J, Anastos K, Adimora A. Effects of antiretroviral therapy and depressive symptoms on all-cause mortality among HIV infected women. Am J Epidemiol 2017 May 15;185(10):869-878. PMC5430940
481 Turan B, Smith W, Cohen MH, Wilson TE, Adimora AA, Merenstein D, Adedimeji A, Wentz EL, Foster AG, Metsch L, Tien PC, Weiser SD, Turan JM. Mechanisms For The Negative Effects Of Internalized Hiv-Related Stigma On Art Adherence In Women: The Mediating Roles Of Social Isolation And Depression. J Acquir Immune Defic Syndr 2016 Feb;72(2):198-205. PMC4868649
480 Valcour VG1, Rubin LH, Obasi MU, Maki PM, Peters MG, Levin S, Crystal HA, Young MA, Mack WJ, Cohen MH, Pierce CB, Adimora AA, Tien PC; Women’s Interagency HIV Study protocol team. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C. J Acquir Immune Defic Syndr 2016 Jul;72(3):266-73. PMC4911304
479 Valdez AN, Rubin LH, Neigh GN. Untangling the Gordian knot of HIV, stress, and cognitive impairment. Neurobiol Stress 2016 Feb 11;4:44-54. PMC5146199
478 Vance DE, Rubin LH, Valcour V, Waldrop-Valverde D, Maki PM. Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women’s Interagency HIV Study. Curr HIV/AIDS Rep 2016 Dec;13(6):399-411. PMC5110037
477 Zhang Y, Waterboer T, Pawlita M, Sugar E, Minkoff H, Cranston RD, Wiley D,  Burk R, Reddy S, Margolick J, Strickler H, Weber K, Gillison M, D’Souza G. Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection. Cancer Epidemiol 2016 Jun 23;43:30-34. Epub 2016 Jun 23. PMC4963265

2015 Publications (38)

476 Aziz M, Mahmood F, Mata M, Durkin HG, Liu C, Greenblatt RM, Nowicki M, Golub ET, Anastos K, French AL, Baum LL. Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters. J AIDS Clin Res 2015 Jul;6(7). Epub 2015 Jul 9. PMC4718584
475 Baxi SM, Greenblatt RM, Bacchetti P, Jin C, French AL, Keller MJ, Augenbraun MH, Gange SJ, Liu C, Mack WJ, Gandhi M. Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients. PLoS One 2015;10(6). PMC4460031
474 Beachler DC, Guo Y, Xiao W, Burk RD, Minkoff H,Strickler HD, Cranston RD, Wiley DJ, Jacobson L, Weber KM, Margolick JB, Sugar EA, Reddy S, Gillison ML, D’Souza G. High oral HPV16 viral load predicts long-term persistence in HIV-infected and at risk HIV-uninfected individuals. J Infect Dis

2015;212(10):1588-1591. PMC4621250

473 Beachler DC, Viscidi R, Sugar EA, Minkoff H, Strickler HD, Cranston RD, Wiley DJ, Jacobson LP, Weber KM, Margolick JB, Reddy S, Gillison ML, D’Souza G.  A longitudinal study of human papillomavirus 16 l1, e6, and e7 seropositivity and oral human papillomavirus 16 infection 1. Sex Transm Dis 2015;42(2):93-97. PMC4295625
472 Beachler D, Sugar E, Margolick J, Weber K, Strickler H, Wiley D, Cranston R, Burk R, Minkoff H, Reddy S, Xiao W, Guo Y, Gillison M, D’Souza G. Risk Factors for Acquisition and Clearance of Oral Human Papillomavirus Infection Among HIV-Infected and HIV-Uninfected Adults. Am J Epidemiol

2015;181(1):40-53. PMC4288119

471 Cates J, Westreich D, Edmonds A, Wright R, Minkoff H, Colie C, Greenblatt R, Cejtin HE, Karim R, Haddad LB, Kempf MC, Golub ET, Adimora A. The effects of viral load burden on pregnancy loss among HIV-infected women in the United States. Infect Dis Obstet Gynecol 2015. PMC4637076
470 Cohen MH, Hotton AL, Hershow RC, Levine A, Bacchetti P, Golub ET, Anastos K, Young M, Gustafson D, Weber KM. Gender-related risk factors improve mortality predictive ability of VACS Index among HIV-infected women. J Acquir Immune Defic Syndr 2015;70(5):538-544. PMC4644433
469 Dale SK, Weber KM, Cohen MH, Kelso GA, Cruise RC, Brody LR. Resilience moderates the association between childhood sexual abuse and depressive symptoms among women with and at-risk for HIV. AIDS Behav 2015;19(8):1379-1387. PMC4314513
468 Goedert JJ, Swenson LC, Napolitano LA, Haddad M, Anastos K, Minkoff H, Young M, Levine A, Adeyemi O, Seaberg EC, Aouizerat B, Rabkin CS, Harrigan PR, Hessol NA. Risk of breast cancer with HIV-using CXCR4 defined by V3-loop sequencing. J Acquir Immun Def Syndr 2015;68(1):30-35. PMC4262599
467 Hanna DB, Post WS, Deal JA, Hodis HN, Jacobson LP, Mack WJ, Anastos K, Gange SJ, Landay AL, Lazar JM, Palella FJ, Tien PC, Witt MD, Xue X, Young MA, Kaplan RC, Kingsley LA. HIV infection is associated with progression of subclinical carotid atherosclerosis. Clin Infect Dis 2015;61(4):640-

650. PMC4607734

466 Hayek SS, Sever S, Ko YA, Trachtman H, Awad M, Wadhwani S, Altintas MM, Wei C, Hotton AL, French AL, Sperling LS, Lerakis S, Quyyumi AA, Reiser J. Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med 2015;373(20):1916-1925. PMC4701036
465 Hessol NA, Martínez-Maza O, Levine AM, Morris A, Margolick JB, Cohen MH, Jacobson LP, Seaberg EC. Lung cancer incidence and survival among HIV-infected and uninfected women and men. AIDS 2015;29(10):1183-1193. PMC4457511
464 Jotwani V, Shlipak MG, Scherzer R, Parekh RS, Kao WH, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Parikh CR, Estrella MM. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women with HIV. Am J Kidney Dis 2015;65(6):889-898. PMC4615696
463 Jotwani V, Scherzer R, Abraham A, Estrella M, Bennett M, Cohen M, Nowicki M, Sharma A, Young M, Tien P, Ix J, Sarnak M, Parikh C, Shlipak M. Association of Urine a1-Microglobulin with Kidney Function Decline and Mortality in HIV-Infected Women. Clin J Am Soc Nephrol 2015;10:63-73. PMC4284407
462 Jung M, Parrinello C, Xue X, Mack W, Anastos K, Lazar J, Selzer R, Shircore A, Plankey M, Tien P, Cohen M, Gange S, Hodis H, Kaplan R. Echolucency of the Carotid Artery Intima-Media Complex and Intima-Media Thickness Have Different Cardiovascular Risk Factor Relationships: The Women’s Interagency HIV Study. J Am Heart Assoc 2015;4(2). PMC4345869
461 Kassaye S, Li Y, Huhn G, Peters MG, French AL, Tien PC, Luxon B, Plankey MW. Direct and Indirect Serum Markers of Liver Fibrosis Compared with Transient Elastography among Women in the Women’s Interagency HIV Study. J AIDS Clin Res 2015;6(4):446. PMC4524652
460 Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Castle PE, Anastos K, Xie X, Minkoff H, Xue X, D’Souza G, Flowers L, Levine AM, Colie C, Rahangdale L, Fischl MA, Palefsky JM, Strickler HD. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test. Clin Infect Dis 2015;61(10):1573-1581. PMC4614409
459 Kuniholm MH, Hanna DB, Landay AL, Kaplan RC, Ley K. Soluble CD163 is associated with non- invasive measures of liver fibrosis in HCV- and HCV/HIV-infected women. Hepatology

2015;61(2):734-735. PMC4291302

458 Lahiri CD, Dugan KB, Xie X, Reimers L, Burk RD, Anastos K, Massad LS, Eltoum IE, Xue X, DʼSouza G, Flowers L, Palefsky JM, Rahangdale L, Strickler HD, Ofotokun I. Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women. J Acquir Immune Defic Syndr 2015;70(2). PMC4573346
457 Lang Kuhs KA, Kuniholm MH, Pfeiffer RM, Chen S, Desai S, Edlin BR, Peters MG, Plankey M, Sharp GB, Strickler HD, Villacres MC, Quinn TC, Gange SJ, Prokunina-Olsson L, Greenblatt RM, O’Brien TR. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes. PLoS One 2015;10(10). PMC4592222
456 Maki PM, Rubin LH, Valcour V, Martin E, Crystal H, Young M, Weber KM, Manly J, Richardson J, Alden C, Anastos K. Cognitive function in women with HIV: Findings from the Women’s Interagency HIV Study. Neurology 2015;84(3):231-240. PMC4335997
455 Massad LS, Evans CT, Weber KM, D’Souza G, Hessol NA, Wright RL, Colie C, Strickler H, Wilson TE. Changes in knowledge of cervical cancer following introduction of human papillomavirus vaccine among women at high risk for cervical cancer. Gynecol Oncol Rep 2015;12:37-40. PMC4392650
454 Massad LS, Xie X, D’Souza G, Darragh TM, Minkoff H, Wright R, Colie C, Sanchez-Keeland L, Strickler HD. Incidence of cervical precancers among HIV-seropositive women. Am J Obstet Gynecol 2015;212(5):606. PMC4416973
453 McKenney J, Bauman S, Neary B, Detels R, French A, Margolick J, Doherty B, Klausner JD. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. Clin Infect Dis 2015;60(6):959-965. PMC4357818
452 Mehta SD, Donovan B, Weber KM, Cohen M, Ravel J, Gajer P, Gilbert D, Burgad D, Spear G. The Vagina Microbiota over an 8-to 10-Year Period in a Cohort of HIV-Infected and HIV-Uninfected Women. PLoS One 2015;10(2). PMC4326357
451 Rubin LH, Meyer VJ, J Conant R, Sundermann EE, Wu M, Weber KM, Cohen MH, Little DM, Maki PM. Prefrontal cortical volume loss is associated with stress-related deficits in verbal learning and memory in HIV-infected women. Neurobiol Dis 2016;92(Pt B):166-174. Epub 2015 Sep 25. PMC4808495
450 Rubin L, Cook J, Weber K, Cohen M, Martin E, Valcour V, Milam J, Anastos K, Young M, Alden C, Gustafson D, Maki P. The association of perceived stress and verbal memory is greater in HIV- infected versus HIV-uninfected women. J Neurovirol 2015;21(4):422-432. PMC4562210
449 Sarkar M, Aouizerat B, Bacchetti P, Prokunina-Olsson L, French A, Seaberg E, O’Brien TR, Kuniholm MH, Minkoff H, Plankey M, Strickler HD, Peters MG. Association of IFNL3 and IFNL4 polymorphisms with liver-related mortality in a multiracial cohort of HIV/HCV-coinfected women. J Viral Hepat 2015;22(12):1055-1060. PMC4618098
448 Scherzer R, Bacchetti P, Messerlian G, Goderre J, Maki PM, Seifer DB, Anastos K, Karim R, Greenblatt RM. Impact of CD4+ lymphocytes and HIV infection on Anti-Mullerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women. Am J Reprod Immunol

2015;73(3):273-284. PMC4323676

447 Sciaranghella G, Wang C, Hu H, Anastos K, Merhi Z, Nowicki M, Stanczyk FZ, Greenblatt RM, Cohen M, Golub ET, Watts DH, Alter G, Young MA, Tsibris AM. CCR5 Expression Levels in HIV- Uninfected Women Receiving Hormonal Contraception. J Infect Dis 2015 Nov;212(9):1397-1401. PMC4601918
446 Shah S, Ma Y, Scherzer R, Huhn G, French A, Plankey M, Peters M, Grunfeld C, Tien PC. Association of HIV, hepatitis C virus and liver fibrosis severity with intreleukin-6 and C-reactive protein levels. AIDS 2015;29(11):1325-1333. PMC447813
445 Sharma A, Hoover DR, Shi Q, Gustafson D, Plankey MW, Hershow RC, Tien PC, Golub ET, Anastos K. Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women’s Interagency HIV Study. PLoS One 2015;10(12). PMC4689347
444 Sharma A, Shi Q, Hoover DR, Anastos K, Tien PC, Young MA, Cohen MH, Golub ET, Gustafson D, Yin MT. Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2015;70(1):54-61. PMC4557627
443 Siewe B, Pham JT, Cohen M, Hessol NA, Levine A, Martínez-Maza O, Landay A. Dysregulated B-cell TLR2 expression and Elevated Regulatory B cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma. AIDS 2015;29(13):1659-1664. PMC4825805
442 Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D’Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med 2015;163(7):507-518. PMC4711936
441 Sundermann EE, Bishop JR, Rubin LH, Little DM, Meyer VJ, Martin E, Weber K, Cohen M, Maki PM. Genetic predictor of working memory and prefrontal function in women with HIV. J Neurovirol 2015 Feb;21(1):81-91
440 Taylor TN, Weedon J, Golub ET, Karpiak SE, Gandhi M, Cohen MH, Levine AM, Minkoff HL, Adedimeji AA, Goparaju L, Holman S, Wilson TE. Longitudinal Trends in Sexual Behaviors with Advancing Age and Menopause Among Women With and Without HIV-1 Infection. AIDS Behav 2015;19(5):931-940. PMC4370800
439 Valcour V, Rubin L, Tien P, Anastos K, Young M, Mack W, Cohen M, Golub E, Crystal H, Maki P. Human Immunodeficiency Virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: A study of the Women’s Interagency HIV Study (WIHS). J Neurovirol 2015;21(4):415-421. PMC4511712

2014 Publications (42)

438 Aka PV, Kuniholm MH, Pfeiffer RM, Wang AS, Tang W, Chen S, Astemborski J, Plankey M, Villacres MC, Peters MG, Desai S, Seaberg EC, Edlin BR, Strickler HD, Thomas DL, Prokunina-Olsson L, Sharp GB, O’Brien TR. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. J Infect Dis 2014;209(3):350-354. PMC3883162
437 Baxi SM, Greenblatt RM, Bacchetti P, Scherzer R, Minkoff H, Huang Y, Anastos K, Cohen M, Gange SJ, Young M, Shlipak MG, Gandhi M. Common Clinical Conditions – Age, Low BMI, Ritonavir Use, Mild Renal Impairment – Affect Tenofovir Pharmacokinetics in a Large Cohort of HIV-Infected Women. AIDS 2014;28(1):59-66. PMC3956315
436 Benning L, Golub E, Anastos K, French A, Cohen M, Gilbert D, Gillevet P, Landay A, Sikaroodi M, Spear G. Comparison of lower genital tract microbiota in HIV-infected and uninfected women from Rwanda and the US. PLoS One 2014;9(5):e96844. PMC4016010
435 Brody LR, Stokes LR, Dale SK, Kelso GA, Cruise RC, Weber KM, Burke-Miller JK, Cohen M. Gender roles and mental health in women with and at risk for HIV. Psychology of Women Quarterly 2014;38(3):311-326. PMC4258411
434 Brody LR, Stokes LR, Kelso GA, Dale SK, Cruise RC, Weber KM, Burke-Miller JK, Cohen MH. Gender

Role Behaviors of High Affiliation and Low Self-Silencing Predict Better Adherence to Antiretroviral Therapy in Women with HIV. AIDS Patient Care and STDs 2014;28(9):459-461. PMC4135315

433 Cook JA, Burke-Miller JK, Grey DD, Cocohoba J, Liu C, Schwartz RM, Golub ET, Anastos K, Steigman PJ, Cohen MH. Do HIV-Positive Women Receive Depression Treatment that Meets Best Practice Guidelines? AIDS Behav 2014;18(6):1094-1102. PMC4020946
432 Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDs 2014;28(3):136-143. PMC3948478
431 Dale S, Cohen M, Kelso G, Cruise R, Weber K, Watson C, Burke-Miller, J, Brody LR. Resilience among women with HIV: Impact of silencing the self and socioeconomic factors. Sex Roles: A Journal of Research 2014;70(5-6):221-231. PMC4051411
430 D’Souza G, Burk RD, Palefsky J, Massad LS, Strickler HD, for the WIHS HPV Working Group. Cervical human papillomavirus testing to triage borderline abnormal Pap tests in HIV-co-infected women. AIDS 2014 Jul;28(11):1696-1698. PMC4196721
429 Frasco MA, Karim R, Van Den Berg D, Watanabe RM, Anastos K, Cohen M, Gange SJ, Gustafson DR, Liu C, Tien PC, Mack WJ, Pearce CL. Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women. AIDS 2014;28(12):1815-

1823. PMC4269472

428 Ghartey J, Kovacs A, Burk RD, Massad LS, Minkoff H, Xie X, D’Souza G, Xue X, Watts HD, Levine AM, Einstein MH, Colie C, Anastos K, Eltoum IE, Herold BC, Palefsky JM, Strickler HD. Genital tract HIV RNA levels and their associations with human papillomavirus infection and risk of cervical precancer. J Acquir Immun Defic Syndr 2014;66(3):316-323. PMC4267467
427 Hanna DB, Hessol NA, Golub ET, Cocohoba JM, Cohen MH, Levine AM, Wilson TE, Young M, Anastos K, Kaplan RC. Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women. JAIDS 2014;65(5):587-596. PMC3999284
426 Hessol NA, Weber KW, D’Souza G, Burton D, Young M, Milam J, Murchison L, Gandhi M, Cohen

MH. Smoking cessation and recidivism in the Women’s Interagency HIV Study. Amer J Prev Med

2014;47(1):53-69. PMC4065848

425 Jotwani V, Scherzer R, Abraham A, Estrella MM, Bennett M, Devarajan P, Anastos K, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Grunfeld C, Parikh CR, Shlipak MG. Does HIV infection promote early kidney injury in women? Antivir Ther 2014;19(1):79-87. PMC3933452
424 Karim R, Mack WG, Kono N, Tien PC, Anastos K, Lazar J, Young M, Desai S, Golub ET, Kaplan RC, Hodis HN, Kovac s A. T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS. J Acquir Immun Def Syndr 2014;67(3):349-356. PMC4197806
423 Kelso GA, Cohen MH, Weber KM, Dale SK, Cruise RC, Brody LR. Critical consciousness, racial and gender discrimination, and HIV disease markers in African American women with HIV. AIDS Behav 2014;18(7):1237-1246. PMC4010552
422 Kiefer E, Hoover D, Shi Q, Kuniholm MH, Augenbraun M, Cohen M, Golub ET, Kaplan RC, Kiu C, Nowicki M, Tien P, Tracy R, Anastos K. Association of markers of hemostasis with death in HIV- infected women. J Acquir Immun Defic Syndr 2014;67(3):287-294. PMC4197808
421 Kuniholm MH, Xie X, Anastos K, Kaplan RC, Xue X, Kovacs A, Peters MG, Seaberg EC, French AL, Young MA, Augenbraun M, Martinson JA, Bush KA, Landay AL, Strickler HD. Association of chronic Hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women. J Acquir Immun Defic 2014;67(3):295-303. PMC4197408
420 Landay A, Golub ET, Desai S, Zhang J, Winkelman V, Anastos K, Durkin H, Young M, Villacres MC, Greenblatt RM, Norris PJ, Busch MP for the Women’s Interagency HIV Study. HIV RNA Levels in Plasma and Cervical Vaginal Lavage Fluid in Elite Controllers and HAART Recipients.  AIDS 2014;28(5):739-743. PMC4160049
419 Massad LS, Pierce CB, Minkoff H, Watts DH, Darragh TM, Sanchez-Keeland L, Wright RL, Colie C, D’Souza G. Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: impact of HIV infection. Int J Cancer 2014;134(8):1854-1861. PMC3947413
418 Massad LS, Xie X, Burk R, Keller MJ, Minkoff H, D’Souza G, Watts DH, Palefsky J, Young M, Levine AM, Cohen M, Strickler HD. Long-term cumulative detection of human papillomavirus among HIV seropositive women. AIDS 2014;28(17):2601-2608. PMC4289460
417 Massad LS, Xie X, Minkoff H, Darragh TM, D’Souza G, Sanchez-Keeland L, Watts DH, Colie C, Strickler HD. Abnormal pap tests and human papillomavirus infections among HIV-Infected and uninfected women who have sex with women. J Low Genit Tract Dis 2014;18(1):50-56. PMC3905442
416 Massad LS, D’Souza G, Darragh TM, Minkoff H, Wright R, Kassaye S, Sanchez-Keeland L, Evans CT. Accuracy of colposcopy in HIV seropositive and seronegative women with abnormal Pap tests. Gynecol Oncol 2014 Dec;135(3):481-486. PMC4268004
415 Mata MM, Iwema JR, Dell S, Neems L, Jamieson B, Phair J, Cohen M, Anastos K, Baum L. Comparison of Antibodies That Mediate HIV Type 1 gp120 Antibody-Dependent Cell-Mediated Cytotoxicity in Asymptomatic HIV Type 1-Positive Men and Women. AIDS Res Hum Retroviruses

2014;30(1):50-57. PMC3887406

414 McKenney J, Smith RM, Chiller TM, Detels R, French A, Margolick J, Klausner JD, Centers for Disease Control and Prevention. Prevalence and correlates of cryptococcal antigen positivity among AIDS patients – United States, 1986-2012. MMWR Morb Mortal Wkly Rep 2014;63(27):585-587. PMC – Exempt
413 Meyer VJ, Little DM, Fitzgerald DA, Sundermann EE, Rubin LH, Martin EM, Weber KM, Cohen MH, Maki PM. Crack cocaine use impairs anterior cingulate and prefrontal cortex function in women with HIV infection. J Neurovirol 2014;20(4):352-361. PMC4090256
412 Mirmirani P, Maurer T, Cohen M, D’Souza G, Karim R, Plankey M, Robison  E, Sharma A, Tien PC, Hessol NA. Investigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV-infected women with and without central lipohypertrophy. Int J Dermatol 2014;53(10):e443-448. PMC3785560
411 Mirmonsef P, Hotton AL, Gilbert D, burgad D, Landay A, Weber KM, Cohen M, Ravel J, Spear GT. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One 2014;9(7):e102467. PMC4102502
410 Peralta C, Scherzer R, Grunfeld C, Abraham A, Tien P, Devarajan P, Bennett M, Butch A, Anastos K, Cohen M, Nowicki M, Sharma A, Young M, Sarnak M, Parikh C, Shlipak M. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women’s Interagency HIV Study (WIHS). HIV Med 2014;15(5):291-300. PMC3975680
409 Pyra M, Weber K, Wilson TE, Cohen J, Murchison L, Goparaju L, Cohen MH. Sexual minority status and violence among HIV infected and at-risk women. J Gen Intern Med 2014;29(8):1131-1138. PMC4099466
408 Pyra M, Weber K, Wilson TE, Cohen J, Murchison L, Goparaju L, Golub ET, Cohen MH. Sexual

Minority Women and Depressive Symptoms Throughout Adulthood. Am J Public Health

2014;104(12):e83-90. PMC4232124

407 Rubin LH, Sundermann EE, Cook JA, Martin EM, Golub ET, Weber KM, Cohen MH, Crystal H, Cederbaum JA, Anastos K, Young M, Greenblatt RM, Maki PM. Investigation of menopausal stage and symptoms on cognition in HIV-infected women. Menopause 2014;21(9):997-1006. PMC4119867
406 Schwartz JB, Moore KL, Yin M, Sharma A, Merenstein D, Islam T, Golub ET, Tien PC, Adeyemi OM. Relationship of vitamin D, HIV, HIV treatment and lipid levels in the Women’s Interagency HIV study (WIHS) of HIV-infected and un-infected women in the US. J Int Assoc Provid AIDS Care 2014;13(3):250-259. PMC4016117
405 Schwartz RM, Weber KM, Schechter GE, Connors NC, Gousse Y, Young MA, Cohen MH. Psychosocial correlates of gender-based violence among HIV-infected and HIV-uninfected women in three US cities. AIDS Patient Care and STDs 2014;28(5):260-267. PMC4011431
404 Shaked I, Hanna DB, Gleißner C, Marsh B, Plants J, Tracy D, Anastos K, Cohen M, Golub ET, Karim R, Lazar J, Prasad V, Tien PC, Young MA, Landay AL, Kaplan RC, Ley K. Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection. Arterioscler Thromb Vasc Biol 2014;34(5):1085-1092. PMC4067091
403 Sharma A, Bynum SA, Schneider MF, Cox C, Tien PC, Hershow RC, Gustafson D, Plankey MW. Changes in Body Mass Index Following HAART Initiation among HIV-infected Women in the Women’s Interagency HIV Study. J AIDS Clin Res 2014 5:323. PMC4285631
402 Shendre A, Irvin MR, Aouizerat BE, Wiener HW, Vazquez AI, Anastos K, Lazar J, Liu C, Karim R, Limdi NA, Cohen MH, Golub ET, Zhi D, Kaplan RC, Shrestha S. RyR3 gene variants in subclinical atherosclerosis among HIV infected women in the Women’s Interagency HIV Study (WIHS). Atherosclerosis 2014;233(2):666-672. PMC3865606
401 Simonetti JA, Gingo MR, Kingsley L, Kessinger C, Lucht LA, Balasubramani GK, Huang L, Jones H, Hessol N, Ponath C, Greenblatt R, Dermand J, Detels R, Kleerup EC, Morris A. Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti-Retroviral Therapy. J AIDS Clin Res

2014;5(11):365. PMC4318265

400 Strickler HD, Martinson J, Desai S, Xie X, Burk RD, Anastos K, Massad LS, Minknoff H, Xue X, D’Souza G, Levine AM, Colie C, Watts DH, Palefsky JM, Landay A. The relations of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV- uninfected women. Viral Immunol 2014;27(1):20-25. PMC3920755
399 Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A. Cause-specific mortality among HIV- infected individuals, by CD4+cell count at HAART initiation, compared with HIV-uninfected individuals. AIDS 2014;28(2):257-265. PMC4164055
398 Williams DW, Byrd D, Rubin L, Anastos K, Morgello S, Berman JW. CCR2 on CD14+CD16+ monocytes is a biomarker of HIV associated neurocognitive disorders. Neurol Neuroimmunol Neuroinflamm 2014;1(3):e36. PMC4204222
397 Wojcik G, Latanich R, Mosbruger T, Astemborski J, Kirk GD, Mehta SH, Goedert JJ, Kim AY, Seaberg EC, Busch M, Thomas DL, Duggal P, Thio CL. Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans. J Infect Dis 2014;209(3):355-359. PMC3883167

2013 Publications (37)

396 Abraham AG, Strickler HD, Jing Y, Gange SJ, Sterling TR, Silverberg M, Saag M, Rourke S, Rachlis A, Napravnik S, Moore RD, Klein M, Kitahata M, Kirk G, Hogg R, Hessol NA, Goedert JJ, Gill MJ, Gebo K, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch R, D’Souza G; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Invasive cervical cancer risk among HIV-infected women: A North American multi-cohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013;62(4):405-413. PMC3633634
395 Adeyemi OM, Livak B, Orsi J, Glesby MJ, Villacres MC, Weber KM, Sharma A, Golub E, Young M, Cohen M, Tien PC. Vitamin D and insulin resistance in non-diabetic women’s interagency HIV study participants. AIDS Patient Care STDS 2013;27(6):320-325. PMC3671624
394 Avdoshina V, Mocchetti I, Liu C, Young MA, Anastos K, Cohen M, Crystal H, Pearce CL, Golub ET, Tractenberg RE.  Single-nucleotide polymorphisms in TrkB and risk for depression: Findings from the Women’s Interagency HIV Study.  J Acquir Immune Defic Syndr 2013;64(2):138-141. PMC3780967
393 Aziz AM, Livak B, Burke-Miller J, French A, Glesby MJ, Sharma A, Young M, Villacres M, Tien PC, Golub ET, Cohen M, Adeyemi OM. Vitamin D insufficiency may impair CD4 recovery among Women’s Interagency HIV Study (WIHS) participants with advanced disease on HAART.  AIDS 2013;27(4):573-578. PMC3902982
392 Bailony MR, Scherzer R, Huhn G, Plankey MW, Peters MG, Tien PC. Association of HIV Infection, Hepatitis C Virus Infection, and Metabolic Factors with Liver Stiffness Measured by Transient Elastography. J Infect Dis 2013;208(11):1776-1783. PMC3814832
391 Cook RL, Zhu F, Belnap BH, Weber KM, Cole SR, Vlahov D, Cook JA, Hessol NA, Wilson TE, Plankey M, Howard AA, Sharp GB, Richardson JL, Cohen MH. Alcohol consumption trajectories in adult women with HIV Infection. AIDS Behav 2013;17(5):1705-1712. PMC3534826
390 Driver TH, Scherzer R, Peralta CA, Tien PC, Estrella MM, Parikh CR, Butch AW, Anastos K, Cohen MH, Nowicki M, Sharma A, Young MA, Abraham A, Shlipak MG. Comparisons of creatinine and cystatin C for detect ion of kidney disease and prediction of all-cuase mortality in HIV-infected women. AIDS 2013;27(14):2291-2299. PMC3919542
389 Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, Carrington M, Thomas DL. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 2013;158(4):235-245. PMC3638215
388 Edwards LL, Reis JS, Weber KM. Facilitators and barriers to discussing HIV prevention with adolescents: perspectives of HIV-infected parents. Am J Public Health 2013;103(8):1468-1475. PMC3908917
387 Estrella MM, Abraham AG, Jing Y, Parikh RS, Tien PC, Merenstein D, Pearce CL, Anastos K, Cohen MH, Dehovitz JA, Gange SJ. Antiretroviral-Treated HIV-Infected Women Have Similar Long-Term Kidney Function Trajectories as HIV-Uninfected Women. AIDS Res Hum Retroviruses

2013;29(5):755-760 PMC3636577

386 Estrella MM, Wyatt CM, Pearce CL, Li M, Shlipak MG, Aouuizerat BE, Gustafson D, Cohen MH, Gange SJ, Kao WH, Parekh RS. Host APOL1 genotype is independently associated with proteinuria in HIV infection. Kidney Int 2013;84(4):834-840. PMC3788838
385 French AL, Evans CT, Agniel DM, Cohen MH, Peters M, Landay AL, Desai SN. Microbial

Translocation and Liver Disease Progression in HIV/ Hepatitis C Co-infected Women. J Infect Dis

2013;208(4):679-689. PMC3719907

384 Gingo MR, Balasubramani GK, Kingsley L, Rinaldo CR, Alden CB, Detels R, Greenblatt RM, Hessol NA, Holman S, Huang L, Kleerup EC, Phair J, Sutton SHM Seaberg EC, Margolick JB, Wisniewski SR, Morris A. The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts. PLoS One 2013;8(3):e58812. PMC3595204
383 Gustafson DR, Mielke MM, Tien PC, Maki P, Valcour V, Cohen M, Anastos K, Liu C, Pearce L, Golub E, Minkoff H, Crystal H. Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women’s Interagency HIV Study. Journal of Neurovirology

2013;19(6):574-585. PMC3957488

382 Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001-2009. PLoS One 2013;8(11):e78952. PMC3832515
381 Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis 2013;56(8):1174-1182. PMC3657490
380 Heilman KJ, Harden ER, Weber KM, Cohen M, Porges SW. Atypicsl autonomic regulation, auditory processing, and affect recognition in women with HIV. Biol Psychol 2013;94(1):143-151. PMC3742727
379 Hessol NA, Ameli N, Cohen M, Urwin S, Weber KM, Tien PC. The association between diet and physical activity on insulin resistance in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2013;62(1):74-80. PMC3529765
378 Hessol NA, Holly EA, Minkoff H, Weber KM, Efird JT, Darragh T, Burk RD, Strickler S, Greenblatt RM, Palefsky JM. Concomitant anal and cervical HPV infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS 2013;27(11):1743-1751. PMC3917497
377 Hussain SK, Hessol NA, Levine AM, Crabb Breen E, Anastos K, Cohen M, D’Souza G, Gustafson DR, Silver S, Martinez-Maza O. Serum biomarkers of immune activation and subsequent risk of non- Hodgkin B cell lymphoma among HIV-infected women. Cancer Epidemiol Biomarkers Prev 2013;22(11):2084-2093. PMC3833437
376 Karim R, Mack WJ, Kono N, Tien PC, Anastos K, Lazar J, Young M, Cohen M, Golub E, Greenblatt RM, Kaplan R, Hodis HN. Gonadotropin and Sex Steroid Levels in HIV-infected Premenopausal Women and Their Association with Subclinical Atherosclerosis in HIV-infected and -uninfected Women in the Women’s Interagency HIV Study (WIHS). J Clin Endocrinol Metab 2013;98(4):e610-618. PMC3615203
375 Karim R, Mack WJ, Stiller T, Operskalski E, Frederick T, Landay A, Young MA, Tien PC, Augenbraun M, Strickler HD, Kovacs A. Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS 2013;27(9):1473-1481. PMC3949252
374 Kiefer EM, Shi Q, Hoover D, Kaplan R, Tracy R, Augenbraun M, Liu C, Nowicki M, Tien P, Cohen M, Golub E, Anastos K. Association of Hepatitis C With markers of hemostatis In HIV-infected and uninfected women in the Women’s Interagency HIV Study (WIHS). J Acquir Immune Defic

Syndr 2012;62(3):301-310. PMC3652915

373 Kuniholm MH, Anastos K, Kovacs A, Gao X, Marti D, Sette A, Greenblatt RM, Peters M, Cohen MH, Minkoff H, Gange SJ, Thio CL, Young MA, Xue X, Carrington M, Strickler HD. Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus. Genes Immun 2013;14(5):330-335. PMC3723800
372 Kuniholm MH, Parrinello CM, Anastos K, Augenbraun M, Plankey M, Nowicki M, Peters M, Golub ET, Lurain N, Landay AL, Strickler HD, Kaplan RC.  Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women. PLoS One 2013;8(4):e61973. PMC3629158
371 Liu C, Wang C, Glesby MJ, D’souza G, French A, Minkoff H, Maurer T, Karim R, Young M. Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study. AIDS Res Ther 2013;10(1):34. PMC3904465
370 McFall AM, Dowdy DW, Zeleya CE, Murphy K, Wilson TE, Young MA, Gandhi M, Cohen MH, Golub ET, Althoff KN; for the Women’s Interagency HIV Study. Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.J Aquir Immune Defic Syndr 2013;64(3):289-298. PMC3816935
369 Meyer VJ, Rubin LH, Martin E, Weber KM, Cohen MH, Golub ET, Valcour V, Young MA, Crystal H, Anastos K, Aouizerat BE, Milam J, Maki PM. HIV and Recent Illicit Drug Use Interact to Affect Verbal Memory in Women. J Acquir Immune Defic Syndr 2013;63(1):67-76. PMC3628722
368 Murphy K, Hoover DR, Shi Q, Cohen M, Gandhi M, Golub ET, Gustafson DR, Pearce C, Young M, Anastos K. Association of self-reported race with AIDS death in continuous HAART users in the women’s interagency HIV study (WIHS). AIDS 2013;27(15):2413-2423. PMC3815041
367 Oboho I, Abraham A, Benning L, Anastos K, Sharma A, Young M, Burian P, Gandhi M, Cohen M

and Szczech L. Tenofovir use and urinary biomarkers among HIV-infected women in the Women’sInteragency HIV Study. J Acquir Immune Defic Syndr 2013;62(4):388-395. PMC3692572

366 Parrinello CM, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Benning L, Tracy RP, Kaplan RC. Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women’s Interagency HIV Study. AIDS 2013;27(9):1516-1519. PMC3909663
365 Plankey M, Baccheti P, Jin C, Dass-Brailsford P, Gustafson D, Cohen MH, Karim R, Yin M, Tien PC. The association of self-perception of body fat changes and quality of life in the Women’s Interagency HIV Study. AIDS Care 2013;25(12):1544-1550. PMC3769511
364 Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk G, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore R, Gange SJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013;8(12):e81355. PMC3867319
363 Sarkar M, Bacchetti P, Tien P, Mileti E, French AL, Edlin BR, Keller M, Seaberg E, Nowicki MJ, Young M, Peters MG. Racial/Ethnic Differences in Spontaneous HCV Clearance in HIV Infected and Uninfected Women. Dig Dis Sci 2013;58(5):1341-1348. PMC3663918
362 Sundermann EE, Bishop JR, Rubin LH, Aouizerat B, Wilson TE, Weber KM, Cohen M, Golub E, Anastos K, Liu C, Crystal H, Pearce CL, Maki PM. HIV serostatus differs by catechol-O- methyltransferase Val158Met genotype. AIDS 2013;27(11):1779-1782. PMC3897122
361 Vassileva J, Ahn W, Weber KM, Busemeyer JR, Stout JC, Gonzalez R, Cohen MH. Computational modeling reveals distinct effects of HIV and history of drug use on decision-making processes in women. PLoS One 2013;8(8):e68962. PMC3737214
360 Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A. Cause-Specific Life Expectancies After 35 Years of Age for Human Immunodeficiency Syndrome-Infected and Human Immunodeficiency Syndrome-Negative Individuals Followed Simultaneously in Long-term Cohort Studies, 1984-2008. Am J Epidemiol 2013;177(2):116-125. PMC3590031

2012 Publications (33)

359 Anziska Y, Helzner E, Crystal H, Glesby M, Plankey M, Weber K, Golub E and Burian P. The relationship between race and HIV-associated sensory neuropathy in a large cohort of US women. J Neuro Sci 2012;315(1-2):129-132. PMC3299869
358 Bambha K, Pierce C, Cox C, French AL, Tien PC, Strickler HD, Sharp GB, Augenbraun M, Glesby MJ, Villacres M, Plankey M, Gange SJ, and Peters MG. Assessing Mortality in Women with Hepatitis C Virus and Human Immunodeficiency Virus using Indirect Markers of Fibrosis. AIDS

2012;26(5):599-607. PMC3698040

357 Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, Burk RD, Wiley DJ, Minkoff H, Reddy S, Stammer EE, Gillison ML, and D’Souza GA. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 2012;21(1):122-133. PMC3280125
356 Cocohoba JM, Althoff KN, Cohen M, Hu H, Cunningham C, Sharma A, Greenblatt RM. Pharmacist counseling in a cohort of women with HIV and women at risk for HIV. Patient Preference and Adherence. 2012;6:457-463. PMC3393123
355 Crystal HA, Hamon S, Randesi M, Cook JA, Anastos K, Lazar J, Liu C, Pearce L, Golub ET, Valcour V, Cohen MH, Holman S, Ho A, and Kreek MJ. A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African-American women. Addict Biol

2012;17(1):181-191. PMC3117061

354 Crystal HA, Kleyman I, Anastos K, Lazar J, Cohen MH, Liu C, Pearce L, Golub ET, Valcour V, Ho A, Strickler H, Peters M, Kovacs A, Kreek MJ, and Manly J. Effects of hepatitis C and HIV on cognition in women: Data from the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr

2012;59(2):149-154. PMC3319079

353 D’Souza GA, Burk R, Zhong Y, Minkoff H, Massad LS, Xue X, Watts DH, Anastos K, Palefsky J, Levine AM, Colie C, Castle P, and Strickler HD. Cervicovaginal HPV Infection Before and After Hysterectomy: Evidence of Different Tissue Tropism for Oncogenic and Non-Oncogenic HPV Types in a Cohort of HIV-positive and HIV-negative Women. Int J Cancer 2012;131(6):1472-1478. PMC3321069
352 D’Souza G, Matson P, Grady CD, Nahvi S, Merenstein D, Weber K, Greenblatt R, Burian P and Wilson TE. Medicinal and recreational marijuana use among HIV-infected women in the Women’s Interagency HIV Cohort (WIHS), 1994-2010. J Acquir Immune Defic Syndr 2012;61(5):618-626. PMC3508315
351 Frasco MA, Mack WJ, Van Den Berg D, Aouizerat BE, Anastos K, Cohen M, DeHovitz J, Golub ET, Greenblatt RM, Liu C, Conti DV, Pearce CL. Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine. AIDS

2012;26(16):2097-2106. PMC3940150

350 Gandhi M, Greenblatt R, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, DeHovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC and Aouizerat B. A Single Nucleotide Polymorphism in CYP2B6 Leads to

>3-fold Increases in Efavirenz Concentrations in Intensive PK Curves and Hair Samples. J Infect Dis

2012;206(9):1453-1461. PMC3466997

349 Homans JD, Christensen S, Stiller T, Wang CH, Mack WJ, Anastos K, Minkoff H, Young M, Greenblatt RM, Cohen M, Stricker HD, Karim R, Spencer LY, Operskalski E, Frederick T, and Kovacs A. Permissive and Protective Factors Associated With Presence, Level and Longitudinal Pattern of Cervicovaginal HIV Shedding. J Acquir Immune Defic Syndr 2012;60(1):99-110. PMC3334315
348 Jean-Louis G, Weber K, Aouizerat B, Levine AM, Maki P, Liu C, Anastos K, Milam J, Althoff KN, and Wilson TE. Insomnia symptoms and HIV infection among participants in the Women’s Interagency HIV Study. Sleep 2012;35(1):131-137. PMC3242680
347 Kaplan RC, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Parrinello CM, Benning L and Tracy RP. Potential cardiovascular disease risk markers among HIV- infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr 2012;60(4):359-

368. PMC3400505

346 Liu C, Wang C, Robison E, Levine AM, Gandhi M, Schwartz R, Weber KM, Merenstein D. Short- term Garlic Supplementation and Highly Active Antiretroviral Treatment Adherence, CD4+ Cell Counts, and Human Immunodeficiency Virus Viral Load. Altern Ther Health Med 2012;18(1):18-22. PMC3376904
345 Maki PM, Rubin LH, Cohen M, Golub ET, Greenblatt RM, Young M, Schwartz RM, Anastos K, & Cook JA. Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse HIV+ and HIV- women. Menopause 2012;19(11):1215-1223. PMC3483358
344 Massad LS, Weber KM, Wilson TE, Goderre JL, Hessol NA, Henry D, Colie C, Strickler HD, Levine AM, Watts DH, and Evans CT. Correlating knowledge of cervical cancer prevention and human papillomavirus with compliance after colposcopy referral. J Lower Genital Tract Dis 2012;16(2):98-

105. PMC3760241

343 Massad LS, Xie X, Greenblatt RM, Minkoff H, Sanchez-Keeland L, Watts DH, Wright RL, D’Souza GA, Merenstein D, and Strickler H. Effect of Human Immunodeficiency Virus Infection on the Prevalence and Incidence of Vaginal Intraepithelial Neoplasia. Obstet Gynecol 2012;119(3):582-

589. PMC3285255

342 Massad LS, D’Souza G, Tian F, Minkoff H, Cohen M, Sanchez-Keeland L, Watts H, Wright RL, Colie C and Hessol NA. Negative predictive value of Pap testing: Implications for screening intervals for women with HIV. Obstet Gynecol 2012;120(4):791-797. PMC3448928
341 Merenstein D, Gandhi M, Wang C, Robison E, Levine AM, Schwartz RM, Weber K, and Liu C. Use of

Vitamin C on HAART Adherence and Effectiveness among Treated HIV+ Women. Complement

Ther Med 2012;20(4):222-227. PMC3351689

340 Merhi ZO, Seifer DB, Weedon J, Adeyemi O, Holman S, Anastos K, Golub ET, Young M, Karim R, Greenblatt R and Minkoff H. Circulating Vitamin D Predicts Serum Anti-Mullerian Hormone Levels in Late Reproductive-Aged Women: Women’s Interagency HIV Study. Fertil Steril 2012;98(1):228-

234. PMC3389125

339 Parrinello CM, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt PW, Deeks SG, Hodis HN, and Kaplan RC. Cytomegalovirus lgG antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis 2012;205(12):1788-1796. PMC3415890
338 Parrinello CM, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Benning L, Tracy RP, Kaplan RC. Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women’s Interagency HIV study. Atherosclerosis 2012;225(2):408-411. PMC3696584
337 Sarkar M, Bacchetti P, French AL, Tien P, Glesby MJ, Nowicki M, Plankey M, Gange S. Sharp G, Minkoff H and Peters MG. Lower Liver-Related Death in African American Women With HIV/HCV Co-Infection Compared to Caucasian and Hispanic Women. Hepatology 2012;56(5):1699-1705. PMC3440547
336 Schwartz RM, Mansoor A, Wilson TE, Anastos K, Everson-Rose SA, Golub ET, Goparaju L, Hessol NA, Mack W, and Lazar J. Chronic Depressive Symptoms and Framingham Coronary Risk in HIV- Infected and Uninfected Women. AIDS Care 2012;24(3):394-403. PMC3243818
335 Sharma A, Tian F, Yin MT, Keller MJ, Cohen M, Tien PC. Association of Regional Body Composition with Bone Mineral Density in HIV-infected and Uninfected Women: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2012;61(4):469-476. PMC3494812
334 Shlipak MG, Scherzer R, Abraham A, Tien PC, Grunfeld C, Peralta CA, Devarajan P, Bennett M, Butch AW, Anastos K, Cohen MH, Nowicki M, Sharma A, Young MA, Sarnak MJ, Parikh CR. Urinary Markers of Kidney Injury and Kidney Function Decline in HIV-Infected Women: Biomarkers and Kidney Decline. J Acquir Immune Defic Syndr 2012;61(5):565-573. PMC3509242
333 Silverberg MJ, Lau B, Justice AC, Engels E, Gill HJ, Goedert JJ, Kirk GD, D’Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, and Dubrow R. Risk of Anal Cancer in HIV- Infected and HIV-Uninfected Individuals in North America. Clin Infect Dis 2012;54(7):1026-1034. PMC3297645
332 Sroussi HY, Burke-Miller J, French AL, Adeyemi OM, Weber KM, Lu Y and Cohen M. Association

Among Vitamin D, Oral Candidiasis, and Calprotectinemia in HIV. J Dent Res 2012 Jul;91(7):666-

670. PMC3383847

331 Sun M, Peipert JF, Zhao Q, Wilson TE, Weber KM, Sanchez-Keeland L, D’Souza G, Young M, Watts H, Keller MJ, Cohan D and Massad S. Trends in Contraceptive Use among Women with the Human Immunodeficiency Virus. Obstet Gynecol 2012;120(4):783-790. PMC3449062
330 Tien P, Schneider M, Cox C, Karim R, Cohen M, Sharma A, Young M and Glesby M. Association of HIV infection with Incident Diabetes Mellitus: Impact of using Hemoglobin A1C as a Criterion for Diabetes. J Acquir Immune Defic Syndr 2012;61(3):334-340. PMC3480977
329 Valcour V, Maki PM, Bacchetti P, Anastos K, Crystal HA, Young MA, Mack WJ, Cohen MH, Golub ET, and Tien PC. Insulin Resistance and Cognition among HIV-infected and HIV-uninfected Adult Women. AIDS Res Hum Retroviruses 2012;28(5):447-453. PMC3332367
328 Villacres M, Kono N, Mack W, Nowicki M, Anastos K, Augenbraun M, Liu C, Landay A, Greenblatt R, Gange S and Levine A. IL10 responses are associated with sustained CD4 T cell counts in treated HIV infection. J Infect Dis 2012;206(5):780-789. PMC3491747
327 Weinberg A, Allshouse AA, MaWhinney S, Canniff J, Benning L, Wentz EL, Minkoff H, Young M, Nowicki M, Greenblatt R, Cohen M and Golub E. Responses to Hepatitis A Virus Vaccine in HIV- Infected Women: Effect of Hormonal Contraceptives and HIV Disease Characteristics. J Acquir Immune Defic Syndr 2012;60(1):e15-e18. PMC3332075

2011 Publications (27)

326 Abraham AG, Lau B, Deeks S, Moore RD, Zhang J, Eron J, Harrigan R, Gill MJ, Kitahata M, Klein M, Napravnik S, Rachlis A, Rodriguez B, Rourke S, Benson C, Bosch R, Collier A, Gebo K, Goedert J, Hogg R, Horberg M, Jacobson L, Justice A, Kirk G, Martin J, McKaig R, Silverberg M, Sterling T, Thorne J, Willig J, Gange SJ for the North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. Missing data on the estimation of the prevalence of accumulated immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in North America. Am J Epidemiol 2011;174(6):727-735. PMC3202147
325 Adeyemi OM, Agniel D, French AL, Tien PC, Weber K, Glesby MJ, Villacres MC, Sharma A, Merenstein D, Golub ET, Meyer W, and Cohen M. Vitamin D deficiency in HIV-infected and HIV- uninfected women in the United States. J Acquir Immune Defic Syndr 2011;57(3):197-204. PMC3431159
324 Althoff KN, Eichelberger M, Gange SJ, Sharp G, Gao J, Glesby MJ, Young MA, Greenblatt RM, French AL, Villacres M, and Minkoff H. Sero-incidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women in the US prior to vaccine availability. AIDS 2011;25(9):1229-1232. PMC3442364
323 Aumakhan B, Gange SJ, Beyrer C, Gaydos CA, Minkoff H, Merenstein DJ, Cohen M, Anastos A, Greenblatt R, Nowicki M, and Quinn TC. Quantitative and qualitative correlates of cervicovaginal herpes simplex virus 2 shedding among HIV-infected women in the Women’s Interagency HIV Study. Int J STD AIDS 2011;22(5):273-277. PMC3123901
322 Avdoshina V, Garzino-Demo A, Bachis A, Monaco MCG, Maki PM, Tractenberg RE, Liu C, Young MA, Mocchetti I. Human Immunodeficiency Virus-1 decreases the levels of neurotrophins in human lymphocytes. AIDS 2011;25(8):1126-1128. PMC3752340
321 Bordon J, Plankey MW, Young MA, Greenblatt RM, Villacres MC, French AL, Zhang J, Brock G, Appana S, Herold B, Durkin H, Golub JE, and Fernandez-Botran R. Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women. Cytokine 2011;56(2):325-

331. PMC3466167

320 Breen EC, Reynolds SM, Cox C, Jacobson LP, Magpantay L, Mulder CB, Dibben O, Margolick JB, Bream JH, Sambrano E, Martinez-Maza O, Sinclair E, Borrow P, Landay AL, Rinaldo CR, and Norris PJ. Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol

2011;18(8):1229-1242. PMC3147360

319 Crystal HA, Weedon J, Randesi M, Lazar J, Manly J, Valcour V, Cohen MH, Anastos K, Liu C, Mack WJ, Golub ET, Ho A, Holman S, Kreek MJ, and Kaplan RC. Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women. J Neurovirol

2011;17(5):469-476. PMC3509940

318 Delwart E, Bernardin F, Lee TH, Winkelman V, Liu C, Sheppard H, Liu A, Greenblatt RM, Anastos K, DeHovitz J, Nowicki M, Cohen MH, Golub ET, Barbour J, Buchbinder S, Busch MP, NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI). Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women. AIDS 2011;25(5):619-623. PMC3458706
317 French AL, Adeyemi OM, Agniel DM, Evans CT, Yin MT, Anastos K, Cohen MH. The Association of

HIV Status with Bacterial Vaginosis and Vitamin D in the Unites States. J Women’s Health

2011;20(10):1497-1503. PMC3233211

316 Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, Young MA, Milam J, Cohen MH, Sharp GB, Huang Y, and Greenblatt RM. Atazanavir Concentration in Hair is the Strongest Predictor of Outcomes on Antiretroviral Therapy. Clin Infect Dis 2011;52(10):1267-1275. PMC3079399
315 Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt P, Karim R, Kern DM, Hodis HN, and Deeks SG. T-cell activation and senescence predict subclinical carotid artery

disease in HIV-infected women. J Infect Dis 2011;203(4):452-463. PMC3071219

314 Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gandhi M, Xue X, Parrinello C, Hunt P, Deeks SG, and Hodis H. T-cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis 2011;217(1):207-213. PMC3139014
313 Keating SM, Golub ET, Heitman JW, Lebedeva M, Nowicki M, Young MA, Strickler H, Crystal C, Zhang J, Greenblatt RM, Desai S, Wu S, Landay AL, Gange SJ, Norris PJ, and the Women’s Interagency HIV Study. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of US women. AIDS 2011;25(15):1823-1832. PMC3314300
312 Kuniholm MH, Gao X, Xue X, Kovacs K, Marti D, Greenblatt RM, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, and Carrington M. Human Leukocyte Antigen (HLA) Genotype and Risk of HIV Disease Progression Before and After Initiation of Antiretroviral Therapy. J Virol 2011;85(20):10826-10833. PMC3187522
311 Kuniholm MH, Gao X, Xue X, Kovacs K, Marti D, Thio CL, Peters MG, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, and Carrington M. The Relation of HLA Genotype with Hepatitis C Viral Load and Markers of Liver Fibrosis in HIV- Infected and HIV-Uninfected Women. J Infect Dis 2011; 203(12):1807-1814. PMC3100515
310 Linas B, Minkoff H, Cohen MH, Karim R, Cohan D, Wright R, Young MA, Watts DH, and Golub ET. Relative time to pregnancy among HIV-infected and uninfected women in the Women’s Interagency HIV Study, 2002-2009. AIDS 2011;25(5):707-711. PMC3496791
309 Liu C, Hu H, Goparaju L, Bacchetti P, Weber K, Correa N, Nowicki M, and Wilson TE. Sexual Serosorting among Women with or at Risk of HIV Infection. AIDS Behav 2011;15(1):9-15. PMC2987377
308 Massad LS, Agniel D, Minkoff H, Watts DH, D’Souza G, Levine AM, Darragh TM, Young MA, Cajigas A, and Weber K. Effect of stress and depression on the frequency of squamous intraepithelial lesions. J Lower Genital Tract Dis 2011;15(1):42-47. PMC3084664
307 Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, Watts DH, Wright R, D’Souza D, Colie C, and Strickler H. Genital Warts and Vulvar Intraepithelial Neoplasia: Natural History and Effects of Treatment and Human Immunodeficiency Virus Infection. Obstet Gynecol 2011;118(4):831-839. PMC3178036
306 Rubin LH, Cook JA, Grey DD, Weber K, Wells C, Golub ET, Wright RL, Schwartz RM, Goparaju L, and Maki PM. Perinatal Depressive Symptoms in HIV-Infected versus HIV-Uninfected Women: A Prospective Study from Preconception to Postpartum. J Women’s Health 2011;20(9):1287-1295. PMC3168970
305 Spear GT, Gilbert D, Landay AL, Zariffard R, French AL, Patel P, and Gillevet PM. Pyrosequencing of the genital microbiotas of HIV-seropositive and –seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species. Appl Environ Microbiol 2011;77(1):378-381. PMC3019699
304 Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, Gill JM, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Klein MB, Martin JN, Rodriguez B, Silverberg MJ, Willig JH, Eron JJ, Goedert JJ, Hogg RS, Justice AC, McKaig RG, Napravnik S, Thorne J, Moore RD; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis 2011;204(6):893-901. PMC31569
303 Wahl SM, Redford M, Christensen S, Mack W, Cohn J, Janoff EN, Mestecky J, Jenson HB, Navazesh M, Cohen M, Reichelderfer P, and Kovac A, for the DATRI 009 Study Group. Systemic and Mucosal Differences in HIV Burden, Immune, and Therapeutic Responses. J Acquir Immune Defic Syndr 2011;56(5):401-411. PMC3164950
302 Wyatt CM, Hoover DR, Shi Q, Tien PC, Karim R, Cohen MH, Goderre JL, Seaberg EC, Lazar J, Young MA, Klotman PE, and Anastos K. Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy. Antivir Ther 2011;16(4):591-596. PMC3119869
301 Wyatt CM, Shi Q, Novak JE, Hoover DR, Szczech L, Semahore M, Binagwaho A, Cohen MH, Mutimura E, and Anastos K. Prevalence of Kidney Disease in HIV-Infected and Uninfected Rwandan Women. PLoS One 2011;6(3):e18352. PMC3065469
300 Yi T, Cocohoba J, Cohen M, Anastos K, DeHovitz JA, Kono N, Hanna DB, and Hessol NA. The Impact of the AIDS Drug Assistance Program (ADAP) on Use of Highly Active Antiretroviral and Antihypertensive Therapy among HIV-Infected Women. J Acquir Immune Defic Synd 2011;56(3):253-262. PMC3042745

2010 Publications (30)

299 Althoff KN, Anastos K, Nelson KE, Celentano DD, Sharp GB, Greenblatt RM, French AL, Diamond DJ, Holman S, Young M, and Gange SJ. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-07 and 2007-08 seasons. Prev Med 2010;50(5-6):223-229. PMC2883293
298 Anastos K, Ndamage, Lu D, Cohen MH, Shi Q, Lazar J, Bigirimana V, and Mutimura E. Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women. AIDS Research and Therapy 2010;7:34. PMC2940781
297 Augenbraun M, French A, Glesby M, Sanchez-Keeland, L, Young MA, Greenblatt RM, and Sharma

A. Hepatitis C Virus (HCV) Infection and False Positive Syphilis Tests. Sex Transm Infect

2010;86(2):97-98. PMC2981071

296 Aumakhan B, Gaydos CA, Quinn TC, Beyrer C, Benning L, Minkoff H, Merenstein DJ, Cohen M, Greenblatt R, Nowicki M, Anastos K, and Gange SJ. Clinical Reactivations of Herpes Simplex Virus Type 2 (HSV-2) Infection and Human Immunodeficiency Virus 1 (HIV-1) Disease Progression Markers. PLoS One 2010;5(4):e9973. PMC2848613
295 Aumakhan B, Hardick A, Quinn TC, Laeyendecker O, Gange SJ, Beyrer C, Cox C, Anastos K, Cohen M, Greenblatt RM, Merenstein DJ, Minkoff H, Nowicki M, and Gaydos CA. Genital Herpes Evaluation by Quantitative TaqMan PCR: Correlating Single Detection and Quantity of HSV-2 DNA in Cervicovaginal Lavage Fluids with Cross-sectional and Longitudinal Clinical Data. Virol J

2010;7(1):328-335. PMC3000844

294 D’Souza G, Palefsky JM, Zhong Y, Minkoff H, Massad LS, Anastos K, Levine AM, Moxley M, Xue XN, Burk RD, and Strickler HD. Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative women. Cancer Epidemiol Biomarkers Prev 2010;19(3):869-872. PMC2874245
293 Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, DeHovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, and Gange SJ. The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women. J Acquir Immune Defic Syndr

2010;55(2):217-220. PMC3243740

292 Galarraga O, Salkever DS, Cook JA, and Gange SJ. An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004. Health Econ 2010;19(2):173-188. PMC2820145
291 Glesby MJ, Hoover DR, Shi Q, Danoff A, Tien P, Merenstein D, Cohen MH, Golub ET, DeHovitz J, Nowicki M, and Anastos K. Glycated Hemoglobin in Diabetic Women with and Without HIV Infection: Data from the Women’s Interagency HIV Study. Antivir Ther 2010;15(4):571-577. PMC2943237
290 Goldberg D, Weber KM, Orsi J, Hessol NA, D’Souza G, Watts DH, Schwartz R, Liu C, Glesby M, Burian P, and Cohen MH. Smoking Cessation Among Women With and At High Risk for HIV: Are They Quitting? J Gen Intern Med 2010;25(1):39-44. PMC2811601
289 Hessol NA, Napolitano LA, Smith D, Lie Y, Levine A, Young M, Cohen M, Minkoff H, Anastos K, D’Souza G, Greenblatt RM, and Goedert JJ. HIV Tropism and Decreased Risk of Breast Cancer. PLoS One 2010;5(12):e14349. PMC3002931
288 Howard AA, Hoover DR, Anastos K, Wu X, Shi Q, Stricker HD, Cole SR, Cohen MH, Kovacs A, Augenbraun M, Latham PS, and Tien PC. The Effects of Opiate Use and Hepatitis C Virus Infection on Risk of Diabetes Mellitus in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr

2010;54(2):152-159. PMC3069645

287 Kovacs A, Karim R, Mack W, Xu J, Chen Z, Operskalski E, Frederick T, Landay AL, Voris J, Spencer L, Young MA, Tien P, Augenbraun M, Strickler HD, and Al-Harthi L. Activation of CD8 T cells predicts progression in women coinfected with hepatitis C virus. J Infect Dis 2010;201(6)823-834. PMC3105602
286 Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, Peters MG, Terrault NA, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Harris TG, Young MA, Strickler HD, and Carrington M. Specific HLA Class I and II Alleles Associated with Hepatitis C Virus Viremia. Hepatology 2010;51(5):1514-1522. PMC2946382
285 Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, Anastos K, Minkoff M, Orenstein J, Dominguez G, and Watts DH. HIV as a Risk Factor for Lung Cancer in Women: Data from the Women’s Interagency HIV Study (WIHS). J Clin Oncol 2010;28(9):1514-1519. PMC2849771
284 Lillie-Blanton M, Stone VE, Snow Jones A, Levi J, Golub E, Cohen M, Hessol NA, and Wilson T. Association of Race, Substance Abuse and Health Insurance Coverage with Use of Highly Active Antiretroviral Therapy Among HIV-infected Women, 2005. Am J Public Health 2010;100(8):1493-

1499. PMC2901300

283 Massad LS, Evans C, Weber K, Goderre J, Hessol N, Henry D, Colie C, Strickler H, Levine AM, Watts DH, and Wilson T. Changes in knowledge of cervical cancer prevention and human papillomavirus among women with HIV, 2006-2008. Obstet Gynecol 2010;116(4):941-947. PMC3248790
282 Massad LS, Evans C, Wilson T, Goderre J, Hessol N, Henry D, Colie C, Strickler H, Levine AM, Watts DH, and Weber K. Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. Gynecol Oncol 2010;117:70-76. PMC3100195
281 Merenstein D, Hu H, Robison E, Levine AM, Greenblatt RM, Schwartz R, Weber K, Young MA, Sharp G, and Liu C. Relationship Between Complementary/Alternative Treatment Use and illicit Drug Use among a Cohort of Women with or at Risk of HIV Infection. J Altern Complement Med

2010;16(9):989-993. PMC3110837

280 Minkoff H, Zhong Y, Burk RD, Palefsky JM, Xue X, Watts DH, Levine AM, Wright RL, Colie C, D’Souza G, Massad LS, and Strickler HD. Influence of Adherent and Effective Antiretroviral Therapy Use on Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV- Positive Women. J Infect Dis 2010;201(5):681-690. PMC2818607
279 Navazesh M, Mulligan R, Kono N, Kumar SKS, Nowicki M, Alves M, and Mack WJ. Oral and Systematic Health Correlates of HIV-1 Shedding in Saliva. J Dent Res 2010;89(10):1074-1079. PMC2970637
278 Palella FJ, Gange SJ, Benning L, Jacobson L, Kaplan RC, Landay AL, Tracy RP, and Elion R. Inflammatory Biomarkers and Abacavir Use in the Women’s Interagency HIV Study and the Multicenter AIDS Cohort Study. AIDS 2010;24(11):1657-1665. PMC3514460
277 Ronquillo RE, Desai SN, Norris PJ, Golub ET, Greenblatt RM, Gange SJ, and Landay AL. Elevated

Caspase-3 Expression and T Cell Activation in Elite Suppressors. J Acquir Immune Defic Syndr

2010;54(1):110-111. PMC3228601

276 Snow Jones A, Lillie-Blanton M, Stone VE, Ip E, Zhang Q, Wilson TE, Cohen MH, Golub ET, and Hessol NA. Multi-Dimensional Risk Factor Patterns Associated with Non-Use of HAART among HIV-Infected Women. Womens Health Issues 2010;20(5):335-342. PMC2930097
275 Tien PC, Schneider MF, Cox C, Cohen MH, Karim R, Lazar J, Young MA, Glesby MJ. HIV, Highly Active Antiretroviral Therapy and Lipoprotein Particle Concentrations in the Women’s Interagency HIV Study. AIDS 2010;24(18):2809-2817. PMC2992832
274 Wilson TE, Girardin JL, Schwartz R, Golub ET, Cohen MH, Maki P, Greenblatt R, Massad LS, Robison E, Goparaju L, and Lindau S. HIV Infection and Women’s Sexual Functioning. J Acquir Immune Defic Syndr 2010;54(4):360-367. PMC2900377
273 Wyatt CM, Hoover DR, Shi Q, Seaberg E, Wei C, Tien PC, Karim R, Lazar J, Young MA, Cohen MH, Klotman PE, and Anastos K. Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Synd 2010;55(1):73-77. PMC2888617
272 Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, Massad LS, Watts H, Kuniholm M, Anastos K, Levine AM, D’Souza G, Moxley M, Palefsky JM, and Strickler HD. Marginal and Mixed Effects Models in the Analysis of HPV Natural History Data. Cancer Epidemiol Biomarkers Prev 2010;19(1):159-169. PMC2839537
271 Yin MT, Lu D, Cremers S, Tien PC, Cohen MH, Shi Q, Shane E, Golub ET, and Anastos K. Short term bone loss in HIV infected premenopausal women. J Acquir Immune Defic Syndr 2010;53(2):202-208. PMC2813405
270 Yin MT, Shi Q, Hoover DR, Anastos K, Sharma A, Young M, Levine A, Cohen MH, Shane E, Golub ET, and Tien PC. Fracture incidence in HIV-infected women: results from the Women’s Interagency HIV Study. AIDS 2010;24(17):2679-2686. PMC3108019

2009 Publications (28)

269 Boodram B, Plankey MW, Cox C, Tien PC, Cohen MH, Anastos K, Karim R, Hyman C, and Hershow RC. Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women’s Interagency HIV Study. AIDS Patient Care STDS 2009;23(12):1009-1016. PMC2832643
268 Cook RL, Zhu F, Herbeck Belnap B, Weber K, Cook JA, Vlahov D, Wilson TE, Hessol NA, Plankey M, Howard AA, Cole SR, Sharp GB, Richardson JL, and Cohen MH. Longitudinal Trends in Hazardous Alcohol Consumption in Women with HIV Infection: 1995-2006. Am J Epidemiol 2009;169(8):1025-1032. PMC2727230
267 Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RC, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, and Moore RD for the North American AIDS Cohort Collaboration on Research and Design. Trends in Multi-Drug Failure and Subsequent Mortality among Antiretroviral Therapy-Experienced HIV-Infected Patients in North America. Clin Infect Dis 2009;49(10):1582-1590. PMC2871149
266 Feldman DN, Feldman JG, Greenblatt RM, Anastos K, Pearce L, Cohen MH, Gange SJ, Leanza S, and Burk R. CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. AIDS Educ Prev 2009;21(3 Suppl):81-93. PMC2754267
265 Frederick T, Burian P, Terrault N, Cohen M, Augenbraun M, Young M, Seaberg E, Justman J, Levine AM, Mack W, and Kovacs A. Factors associated with prevalent Hepatitis C infection among HIV- infected women with no reported history of injection drug use: The Women’s Interagency HIV Study (WIHS). AIDS Patient Care STDS 2009;23(11):915-923. PMC2823487
264 French A, Gawel S, Hershow R, Benning L, Hessol N, Levine A, Anastos K, Augenbraun M, and Cohen M. Trends in Mortality and Cause of Death among Women with HIV in the US: A Ten-year Study. J Acquir Immune Defic Syndr 2009;51(4):399-406. PMC2769934
263 French A, Lin MY, Evans CT, Benning L, Glesby M, Young MA, Operskalski EA, Augenbraun M, and Peters M. Long-term Serologic Follow-up of Isolated Hepatitis B Core Antibody in HIV-infected and Uninfected Women. Clin Infect Dis 2009;49(1):148-154. PMC2743413
262 Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, and Greenblatt RM for the Women’s Interagency HIV Study (WIHS). Protease inhibitor levels in hair samples strongly predict virologic responses to HIV treatment. AIDS 2009;23(4):471-478. PMC2654235
261 Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, and Greenblatt RM. NNRTI pharmacokinetics in a large unselected cohort of HIV- infected women. J Acquir Immune Defic Syndr 2009;50(5):482-491. PMC2700138
260 Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TM, Burk RD, Strickler HD, Greenblatt RM and Palefsky JM . Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 2009;23(1):59-70. PMC2614220
259 Hessol NA, Weber K, Holman S, Alden C, Goparaju L, Kono N, Robison E, Watts H, and Ameli N. Retention and Attendance of Women Enrolled in a Large Prospective Study of HIV-1 in the United States. J Women’s Health 2009;18(10):1627-1637. PMC2825719
258 Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD for the NA-ACCORD Investigators. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009;360(18):1815-1826. PMC2854555
257 Lazar JM, Wu X, Shi Q, Kagame A, Cohen M, Binagwaho A, Munyakezi L, Salciccioli L, Shi D, and Anastos K. Arterial wave reflection in HIV-infected and HIV-uninfected Rwandan women. AIDS Res Hum Retroviruses 2009;25(9):877-882. PMC2858930
256 Liu C, Yang Y, Gange SJ, Weber K, Sharp G, Wilson TE, Levine A, Robison E, Goparaju L, Gandhi M, and Merenstein D. Disclosure of Complementary and Alternative Medicine Use to Health Care Providers among HIV-infected Women. AIDS Patient Care STDS 2009;23(11):965-971. PMC2801553
255 Maki PM, Cohen MH, Weber K, Little DM, Fornelli D, Perschler P, Gould F, and Martin E. Impairments in Memory and Hippocampal Function in HIV+ Versus HIV- Women: A Preliminary Study. Neurology 2009;72(19):1661-1668. PMC2683643
254 Massad LS, Seaberg EC, Watts DH, Minkoff H, Levine AM, Henry D, Colie C, Darragh TH, and Hessol N. Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer 2009;115(3):524-530. PMC2641995
253 Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, D’Souza G, Cajigas A, Colie C, Watts DH, and Strickler H. Histologic correlates of glandular abnormalities in cervical cytology among women with HIV. Obstet Gynecol 2009;114(5):1063-1068. PMC3032588
252 Merenstein DJ, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi M, Richardson J and Plankey MW. Association of child care burden and household composition with adherence to Highly Active Antiretroviral Therapy in the Women’s Interagency HIV Study. AIDS Patient Care STDS 2009;23(4):289-296. PMC2674283
251 Navazesh M, Mulligan R, Karim R, Mack WJ, Ram S, Seirawan H, Greenspan J, Greenspan D, Phelan J and Alves M. Effect of HAART on salivary gland function in the Women’s Interagency HIV Study (WIHS). Oral Dis 2009;15(1):52-60. PMC2644059
250 Ouyang DW, Shapiro D, Lu M, Brogly S, French AL, Thompson B, Tuomala RE, and Hershow R. Increased Risk of Hepatotoxicity in HIV-infected Pregnant Women Receiving Antiretroviral Therapy Independent of Nevirapine Exposure. AIDS 2009;23(18):2425-2430. PMC2783653
249 Plankey M, Bacchetti P, Jin C, Grimes B, Hyman C, Cohen M, Howard AA, and Tien PC. Self- Perception of Body Fat Changes and HAART Adherence in the Women’s Interagency HIV Study. AIDS Behav 2009;13(1):53-59. PMC2902995
248 Richardson JL, Heikes B, Karim R, Weber K, Anastos K, and Young M. Experience of pain among women with advanced HIV disease. AIDS Patient Care STDS 2009;23(7):503-511. PMC2792586
247 Seifer D, Golub E, Lambert-Messerlain G, Benning L, Anastos K, Watts DH, Cohen M, Karim R, Young M, Minkoff H, and Greenblatt R. Variations in Serum Mullerian Inhibiting Substance Between White, Black and Hispanic Women. Fertil Steril 2009;92(5):1674-1678. PMC3037722
246 Silverberg MJ, Jacobson L, French A, Witt MD, and Gange S. Age and Racial/Ethnic Differences in the Prevalence of Reported Symptoms in HIV-Infected Persons on Antiretroviral Therapy. J Pain Symptom Manage 2009;38(2):197-207. PMC2858004
245 Terzian AS, Holman S, Nathwani N, Robison E, Weber K, Young M, Greenblatt RM, and Gange SJ. Factors associated with preclinical disability and frailty among HIV-infected and -uninfected women in the era of cART. J Women’s Health 2009;18(12):1965-1974. PMC2828186
244 Tien PC, Schneider MF, Cole S, Cohen M, Glesby M, Lazar J, Nowicki M, Young M, and Kaplan RC. Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the Women’s Interagency HIV Study. AIDS 2009;23(13):1781-1784. PMC2847440
243 Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, Cohen MH, Peters MG, Golub ET, and Szczech L. Hepatitis C Seropositivity and Kidney Function Decline Among Women with HIV: Data From the Women’s Interagency HIV Study. Am J Kidney Dis 2009;54(1):43-50. PMC2997705
242 Womack JA, Scherzer R, Cole SR, Fennie K, Williams AB, Grey M, Minkoff H, Anastos K, Cohen MH, and Tien PC. Hormonal Contraception and Metabolic Outcomes in Women With or at Risk for HIV Infection. J Acquir Immune Defic Syndr 2009;52(5):581-587. PMC2886798

2008 Publications (22)

241 Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA and Greenblatt RM. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV- infected women. J Acquir Immune Defic Syndr 2008;47:377-383. PMC – Exempt
240 Cook J, Burke-Miller J, Cohen M, Cook R, Vlahov D, Wilson T, Golub ET, Schwartz R, Howard A, Ponath C, Plankey M and Grey D. Crack cocaine, disease progression, and mortality in a multi- center cohort of HIV-1 positive women. AIDS 2008;22:1355-1363. PMC2645902
239 Dolev J, Maurer T, Springer G, Glesby M, Minkoff H, Connell C, Young M, Schowalter K, Cox C and Hessol N. Incidence and risk factors for verrucae in women. AIDS 2008;22:1213-1219. PMC2615554
238 Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M and Gange SJ. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. Clin Infect Dis 2008;46:305-312. PMC – Exempt
237 Harris TG, Burk RD, Yu H, Minkoff H, Massad LS, Watts DH, Zhong Y, Gange S, Kaplan RC, Anastos K, Levine AM, Moxley M, Xue X, Fazzari M, Palefsky JM and Strickler HD. Insulin-like growth factor axis and oncogenic human papillomavirus natural history. Cancer Epidemiol Biomarkers Prev

2008;17:245-248. PMC – Exempt

236 Justman JE, Hoover DR, Shi Q, Tan T, Anastos K, Tien PC, Cole SR, Hyman C, Karim R, Weber K and Grinspoon S. Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women. J Acquir Immune Defic Syndr 2008;47:312-319. PMC – Exempt
235 Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, Cook JA, Goparaju L, Golub ET, Richardson J and Wilson TE. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse 2008;34:161-

170. PMC – Exempt

234 Kovacs A, Al-Harthi L, Christensen S, Mack W, Cohen M and Landay A. CD8(+) T cell activation in women coinfected with Human Immunodeficiency Virus Type 1 and hepatitis C virus. J Infect Dis

2008;197:1402-1407. PMC2443164

233 Massad LS, Evans CT, D’Souza G, Darragh T, Minkoff H, Henry D, Goparaju L, Muderspach LI, and

Watts DH. High-grade cervical disease in adolescents with HIV. J Low Genit Tract Dis 2008;12:199-

203. PMC – Exempt

232 Massad LS, Evans CT, Wilson TE, Golub ET, Goparaju L, Howard A, Greenblatt RM, Weber K and Schilder K. Impact of menopause on condom use by HIV-seropositive and comparison seronegative women. J Acquir Immune Defic Syndr 2008;47(3):401-402. PMC – Exempt
231 Massad LS, Seaberg EC, Wright R, Darragh T, Lee Y, Colie C, Burk R, Strickler H and Watts H. Squamous cervical lesions in women with HIV: Long-term follow-up in the Women’s Interagency HIV Study. Ob Gyn 2008;111:1388-1393. PMC – Exempt
230 Merenstein DJ, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi M, Richardson J and Plankey MW. Association between living with children and adherence to highly active antiretroviral therapy in the Women’s Interagency HIV Study. Pediatrics 2008;121:e787-e793. PMC2651400
229 Merenstein D, Yang Y, Schneider M, Goparaju L, Weber K, Sharma A, Levine AM, Sharp GB, Gandhi M and Liu C. Association of Complementary and Alternative Medicine Use with HAART Initiation. Altern Ther Health Med 2008;14:18-22. PMC2651402
228 Minkoff H, Zhong Y, Strickler HD, Watts DH, Palefsky JM, Levine AM, D’Souza G, Howard AA, Plankey M, Massad LS and Burk R. The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women. Infect Dis Obstet Gynecol 2008;2008:587082. PMC2324195
227 Nowicki MJ, Vigen C, Mack WJ, Seaberg E, Landay A, Anastos K, Young M, Minkoff H, Greenblatt R and Levine AM. Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women. AIDS Res Hum Retroviruses 2008;24:163-168. PMC – Exempt
226 Operskalski EA, Mack WJ, Strickler HD, French AL, Augenbraun M, Tien PC, Villacres MC, Spencer LY, DeGiacomo M and Kovacs A. Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women. J Clin Virol 2008;41:255-263. PMC – Exempt
225 Sobieszczyk ME, Hoover D, Anastos K, Mulligan R, Tan T, Shi C, Hyman C, Cohen M, Cole S, Plankey M and Justman J. Prevalence and predictors of metabolic syndrome among HIV-positive and negative women in the Women’s Interagency HIV Study. J Acquir Immune Defic Synd 2008;48:272-280. PMC – Exempt
224 Spear GT, Zariffard MR, Cohen MH, and Sha BE. Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women. J Reprod Immunol 2008;78(1):76-79. PMC2413097
223 Spear GT, Sikaroodi M, Zariffard MR, Landay AL, French AL and Gillevet PM. Comparison of the Diversity of the Vaginal Microbiota in HIV-infected and HIV-uninfected Women with or without Bacterial Vaginosis. JID 2008;198:1131-1140. PMC2800037
222 Strickler HD, Howard AA, Peters M, Fazzari M, Yu H, Augenbraun M, French AL, Young M, Gange S, Anastos K and Kovacs A. The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women. AIDS 2008;22:527-531. PMC – Exempt
221 Strickler HD, Fazzari M, Kovacs A, Isasi C, Napolitano LA, Minkoff H, Gange S, Young M, Sharp GB, Kaplan RC, Cohen M, Gunter MJ, Harris TG, Yu H, Schoenbaum E, Landay AL and Anastos K. Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women. J Infect Dis 2008;197:319-327. PMC – Exempt
220 Tien P, Schneider M, Cole S, Levine A, Cohen M, DeHovitz J, Young M, and Justman J. Antiretroviral Therapy Exposure and Insulin Resistance in the Women’s Interagency HIV Study. J Acquir Immune Defic Synd 2008;49:369-376. PMC – Exempt

2007 Publications (27)

219 Anastos K, Lu D, Shi Q, Mulligan R, Tien P, Freeman R, Cohen M, Justman J and Hessol N. The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther 2007;12(7):1049-1058.
218 Anastos K, Lu D, Shi Q, Tien P, Kaplan R, Hessol N, Cole S, Vigen C, Cohen M, Young M and Justman J. The association of serum lipid levels with HIV serostatus, specific antiretroviral agents and treatment regimens. J Acquir Immune Defic Synd 2007;45(1):34-42.
217 Azzoni L, Chehimi J, Zhou L, Foulkes AS, June R, Maino VC, Landay A, Rinaldo C, Jacobson LP, and Montaner LJ. Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells. AIDS 2007;21:293-305.
216 Cohen MH, Grey D, Cook JA, Anastos K, Seaberg E, Augenbraun M, Burian P, Peters M, Young M and French A. Awareness of hepatitis C infection among women with and at risk for HIV. J Gen Intern Med 2007;22:1689-1694. PMC2219830
215 Cook J, Grey D, Burke J, Cohen M, Vlahov D, Kapadia F, Wilson T, Schwartz R, Cook R, Golub ET, Anastos K, Ponath C, Goparaju L and Levine A. Illicit drug use, depression, and their association with highly active antiretroviral therapy in HIV-positive women. Drug and Alcohol Dependence 2007;89(1):74-81.
214 D’Souza G, Fakhry C, Sugar E, Seaberg EC, Weber K, Minkoff H, Anastos K, Palefsky J and Gillison

M. Six-month natural history of oral versus cervical HPV infection. Int J Cancer 2007;121(1):143-

150.

213 French AL, Operskalski E, Peters M, Strickler H, Tien P, Sharp G, Glesby M, Young M, Augenbraun M, Seaberg EC and Kovacs A. Isolated hep B core antibody is associated with HIV and ongoing but not resolved Hep C infection in a cohort of US women. J Infect Dis 2007;195(10):1437-1442.
212 Harris TG, Burk RD, Xue X, Anastos K, Minkoff H, Massad LS, Young MA, Levine AM, Gange SJ, Watts DH, Palefsky JM, and Strickler HD. Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women. AIDS 2007;21:1933-1941.
211 Hessol N, Kalinowski A, Benning L, Mullen J, Young M, Palella F, Anastos K, Detels R and Cohen M. Accident and injury-related mortality among participants in the multicenter AIDS cohort study (MACS) and the women’s interagency HIV study (WIHS). CID 2007;44(2):287-294.
210 Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, Mack WJ, Cohen MH, Jacobson L and Gange SJ. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis 2007;45:1074-1081.
209 Khalsa A, Karim R, Mack WJ, Minkoff H, Cohen M, Young M, Anastos K, Tien PC, Seaberg E and Levine AM. Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women’s Interagency HIV Study. AIDS 2007;21:2539-2541.
208 Liu C, Lerch V, Weber K, Schneider MF, Sharp GB, Goparaju L, Sharma A, Levine A, Gandhi M and Merenstein D. Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women’s Interagency HIV Study. J Altern Complement Med 2007;13:1053-1056.
207 Lopez-Gatell H, Cole S, Hessol N, French A, Greenblatt R, Landesman S, Preston-Martin S and Anastos K. Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol 2007;165:1134-1142.
206 Massad LS, Evans CT, Weber K, Cejtin H, Golub ET, DiGilio K, Alpern A and Watts DH. Hysterectomy among women with HIV: indications and incidence. J Acquir Immune Defic Synd 2007;44(5)566-568.
205 Massad LS, Evans CT, Wilson T, Golub ET, Sanchez-Keeland I, Minkoff H, Weber K and Watts H. Contraceptive use among US women with HIV. J Womens Health (Larchmt) 2007;16(5):657-666.
204 Massad LS, Fazzari M, Anastos K, Klein R, Minkoff H, Jamieson D, Duerr A, Celentano D, Gange S, Cu-Uvin S, Young M, Watts H, Levine A, Schuman P, Harris T and Strickler H. Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis

2007;11(2):90-97.

203 Morris J, Golub ET, Mehta S, Jacobson L and Gange S. Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts. AIDS Research and Therapy 2007;4:12. PMC1892565
202 Neely M, Benning L, Xu J, Strickler H, Greenblatt R, Minkoff H, Young M, Bremer J, Levine A and Kovacs A. Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic 2007;44(1):38-42.
201 Nowicki M, Karim R, Mack W, Minkoff H, Anastos K, Cohen M, Greenblatt R, Young M, Gange S and Levine A. Correlates of CD4+ and CD8+ lymphocyte counts in HIV- women: WIHS. Hum Immunol 2007;68(5):342-349.
200 Seifer D, Golub ET, Lambert-Messerlain G, Springer G, Holman S, Moxley M, Cejtin H, Nathwani N, Anastos K, Minkoff H and Greenblatt R. Biologic makers of ovarian reserve and reproductive

aging: application in a cohort study of HIV infection in women. Fertil Steril 2007;88(6):1645-1652.

199 Sha BE, Gawel SH, Hershow RC, Passaro D, Augenbraun M, Darragh TM, Stek A, Golub ET, Cashin L, Moxley MD, Weber KM and Watts DH. Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis. J Low Genit Tract Dis 2007;11:240-250.
198 Tien PC, Barrón Y, Justman J, Hyman C, Cohen M, Young M, Kovacs A and Cole S. Antiretroviral therapies associated with lipoatrophy in HIV-infected women. AIDS Patient Care STDs 2007;21:1739-1745.
197 Tien PC, Schneider MF, Cole S, Justman JE, French AL, Young M, DeHovitz J, Nathwani N and Brown TT. Relation of stavudine discontinuation to anthropometric changes among HIV-infected women. JAIDS 2007;44(1):43-48.
196 Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M and Justman JE. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women’s Interagency HIV Study. AIDS 2007;21:1739-1745.
195 Tsui JI, French AL, Seaberg EC, Augenbraun M, Nowicki M, Peters M and Tien PC. Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis 2007;45:736-740.
194 Wilson T, Feldman J, Vega M, Gandhi M, Richardson J, Cohen M, McKaig R, Ostrow E, Robison E and Gange S. Acquisition of new sexual partners among women with HIV-infection: patterns of disclosure and sexual behavior within new partnerships. AIDS Educ Prev 2007;19(2):151-159.
193 Womack J, Tien PC, Feldman J, Shin JH, Fennie K, Anastos K, Cohen MH, Bacon MC and Minkoff H. Obesity and immune cell counts in women. Metabolism 2007;56:998-1004. PMC1939725

2006 Publications (20)

192 Al Harthi L, Voris J, Du W, Wright DJ, Nowicki M, Frederick T, Landay A, and Kovacs A. Evaluating the impact of HCV on HAART-mediated immune responses in HCV/HIV co-infected women: Role of HCV on expression of memory T-cells. J Infect Dis 2006;193(9):1202-1210.
191 Ameli N, Bacchetti P, Ashley R, Hessol N, Wilkin T, Young M, Cohen M, Kovacs A, Minkoff H, Gange S, and Greenblatt R. Herpes simplex virus infection in women in the WIHS: Epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS 2006;20:1051-1058.
190 Burke-Miller JK, Cook JA, Cohen MH, Hessol NA, Wilson TE, Richardson JL, Williams P and Gange SJ. Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS. Am J Public Health 2006;96(6):1044-1051. PMC1470631
189 Cejtin H, Kalinowski A, Bacchetti P, Taylor R, Watts H, Kim S, Massad LS, Preston-Martin S, Anastos D, Moxley M, and Minkoff H. Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction. Obstet Gynecol 2006;108(6):1423-1431.
188 Cook J, Grey D, Burke J, Cohen M, Anastos K, Gandhi M, Richardson J, Wilson T, and Young M. Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy (HAART) use in a U.S. multi-site cohort of HIV-positive women. AIDS Care 2006;18(2):93-100.
187 Fakhry C, D’Souza G, Sugar E, Weber K, Goshu E, Minkoff H, Wright R, Seaberg E, and Gillison M. The relationship between prevalent oral and cervical HPV infections in HIV-positive and negative women. J Clin Microbiol 2006;44(12):4479-4485. PMC1698387
186 Feldman J, Minkoff H, Schneider MF, Gange S, Cohen M, Watts H, Gandhi M, Young M, Mocharnuk R, and Anastos K. Impact of cigarette smoking on HIV prognosis among women in the HAART era- a report from the WIHS. Am J Public Health 2006;(96)6:1060-1065. PMC1470629
185 French AL, Evans CT, Anastos K, Greenblatt RM, Hershow R, Huebner R, Augenbraun M, Young M, Lopez-Gatell H, and Passaro DJ. Incidence of tuberculin Skin test conversion among HIV-infected and -uninfected women: results of a 6-year study. J Acquir Immune Defic Syndr 2006;42(5):592-596.
184 Galarraga O, Salkever S, Cook JA, and Gange SJ. An instrumental variable evaluation of antidepressant use on employment among HIV-infected women using highly-active antiretroviral therapy in the United States: 1996-2004. NBER Working Paper 2006;12619:1-42.
183 Gange SJ, Schneider MF, Grant RM, Liegler T, French A, Young M, Anastos K, Wilson TE, Ponath C, and Greenblatt R. Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure. J Acquir Immune Defic Syndr 2006;95:642-648.
182 Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, and Engels EA. Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer 2006:1-7.
181 Gordeuk VR, Onojobi G, Schneider MF, Dawkins FW, Delapenha R, Voloshin Y, von Wyl V, Bacon M, Minkoff H, Levine A, Cohen M, and Greenblatt R. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologic 2006;91(6):739-743.
180 Kim JS, Nag P, Landay AL, Alves M, Cohn MH, Bremer JW, and Baum LL. Saliva can mediate HIV-1- specific antibody-dependent cell-mediated cytotoxicity. FEMS Immunol Med Microbiol

2006;48:267-273.

179 Levine A, Karim R, Mack W, Gravink DJ, Anastos K, Young M, Cohen M, Newman M, Augenbraun M, Gange S, and Watts H. Neutropenia in the setting of HIV: correlates and significance in a large cohort of HIV+ women. Arch Intern Med 2006;166:405-410.
178 Liu C, Weber K, Robison E, Hu Z, Jacobson L, and Gange S. Assessing the effect of HAART on QOL

among HIV-infected women. AIDS Research and Therapy 2006;3(6):1-11. PMC1459186

177 Massad LS, Evans CT, Minkoff H, Watts DH, Greenblatt RM, Levine AM, Anastos K, Young M, Seifer DB, Golub ET, and Cohen M. Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. J Womens Health (Larchmt) 2006;15:591-598.
176 Minkoff H, Xian S, Watts H, Leighty R, Hershow R, Palefsky J, Tuomala R, Neu N, Zorrilla C, Paul M, and Strickler H. Relationship of pregnancy to HPV among HIV-infected women. Obstet Gynecol 2006;108(4):953-960.
175 Silverberg MJ, Schneider MF, Silver B, Massad LS, Anastos K, Burk R, Minkoff H, Palefsky J, Levine A, Strickler H, and Viscidi R. Serological detection of HPV type-16 infection in HIV+ and high-risk HIV- women. Clinical and Vaccine Immunology 2006;13:511-519. PMC1459636
174 Vaamonde CM, Hoover DR, Anastos K, Tan T, Shi Q, Gao W, Kovacs A, Cohen M, DeHovitz J, and Glesby MJ. Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women. AIDS Res Hum Retroviruses 2006;22(3):222-231.
173 Watts DH, Springer G, Minkoff H, Hillier SL, Jacobson L, Moxley M, Justman J, Cejtin H, O’Connell C, and Greenblatt RM. The occurrence of vaginal infections among HIV-infected and high-risk HIV- uninfected women: longitudinal findings of the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2006;43:161-168.

2005 Publications (29)

172 Anastos K, Schneider MF, Gange S, Minkoff H, Greenblatt R, Feldman J, Levine A, Delapenha R, and Cohen M. The Association of Race, Sociodemographic, and Behavioral Characteristics With Response to Highly Active Antiretroviral Therapy in Women. J Acquir Immune Defic Syndr 2005;39(5):537-544.
171 Ahdieh-Grant L, Tarwater PM, Schneider MF, Anastos K, Cohen M, Khalsa A, Minkoff H, Young M, and Greenblatt RM. Factors and Temporal Trends Associated With Highly Active Antiretroviral Therapy Discontinuation in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2005;38:500-503.
170 Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange S, Barranday Y, Holman S, Weber K, and Young MA. The Women’s Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench. Clin Diagn Lab Immunol 2005;12:1013-1019. PMC1235804
169 Chu H, Moulton L, Mack W, Passaro D, Barroso P, and Muñoz A. Correlating Two Continuous

Variables Subject to Detection Limits in the Context of Mixture Distributions. Applied Statistics

2005;54:831-845.

168 Chu J, Gange SJ, Anastos K, Minkoff H, Cejtin H, Bacon M, Levine A, and Greenblatt RM. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. Am J Epidemiol 2005;161:881-890.
167 Cohen MH, D’Adesky AC, and Anastos K. Women in Rwanda: another world is possible. JAMA

2005;294:613-615.

166 Cole SR, Hernan MA, Margolick JB, Cohen MH, and Robins JM. Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol 2005;162:471-478.
165 Danoff A, Shi Q, Justman J, Mulligan K, Hessol N, Robison E, Lu D, Williams T, Wichienkuer P, and Anastos K. Oral Glucose Tolerance and Insulin Sensitivity Are Unaffected by HIV Infection or Antiretroviral Therapy in Overweight Women. J Acquir Immune Defic Syndr 2005;39:55-62.
164 Gandhi M, Ameli N, Bacchetti P, Sharp G, French A, Young M, Gange S, Anastos K, Holman S, Levine A, and Greenblatt R. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. AIDS 2005;19:1885-1896.
163 Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, Watts DH, Silverberg MJ, Xue X, Melnick SL, and Strickler HD. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 2005;293:1471-1476.
162 Hernan MA, Cole SR, Margolick JB, Cohen M, and Robins J. Structural accelerated failure time models for survival analysis in studies with time-varying treatments. Pharmacoepidemiol Drug Saf 2005;14(7):477-491.
161 Hessol N and Scheer S. Epidemiology of Cancer in the Pre-HAART and HAART Eras. Viral and

Immunologic Malignancies, edited by Volberding and Palefsky, Dekker Publishing 2005.

160 Kapadia F, Cook JA, Cohen MH, Sohler N, Kovacs A, Greenblatt RM, Choudhary I, and Vlahov D. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction 2005;100:990-1002.
159 Latka MH, Wilson TE, Cook JA, Bacon MC, Richardson JL, Sohler N, Cohen MH, Greenblatt RM, Andreopoulis E, and Vlahov D. Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: A report from the Women’s Interagency HIV Study. J Subst Abuse Treat 2005;29:329-337.
158 Massad LS, Evans CT, Strickler HD, Burk RD, Watts DH, Cashin L, Darragh T, Gange S, Lee YC, Moxley M, Levine A, and Passaro DJ. Outcome After Negative Colposcopy Among Human Immunodeficiency Virus-Infected Women With Borderline Cytologic Abnormalities. Obstet Gynecol 2005;106:525-532.
157 Mulligan K, Anastos K, Justman J, Freeman R, Wichienkuer P, Robison E, and Hessol NA. Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2005;38:18-22.
156 Napolitano L, Burt T, Bacchetti P, Barrón Y, French A, Kovacs A, Anastos K, Young M, McCune J, and Greenblatt R. Increased circulating interleukin-7 levels in HIV-1-infected women. J Acquir Immune Defic Syndr 2005;40(5):581-584.
155 Navazesh M, Mulligan R, Pogoda J, Greenspan D, Alves M, Phelan J, Greenspan J, and Slots J. The effect of HAART on salivary microbiota in the Women’s Interagency HIV Study (WIHS). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:701-708.
154 Prins M, Meyer L, and Hessol NA. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS 2005;19:357-370.
153 Richardson JL, Nowicki M, Danley K, Martin EM, Cohen MH, Gonzalez R, Vassileva J, and Levine AM. Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women. AIDS 2005;19:1659-1667.
152 Schlecht NF, Burk RD, Palefsky JM, Minkoff H, Xue X, Massad LS, Bacon M, Levine AM, Anastos K, Gange SJ, Watts DH, Costa MM, Chen Z, Bang JY, Fazzari M, Hall C, and Strickler HD. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus- positive women. J Gen Virol 2005;86:2709-2720.
151 Sha BE, Chen HY, Wang QJ, Zariffard MR, Cohen MH, and Spear GT. Utility of Amsel Criteria, Nugent Score, and Quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for Diagnosis of Bacterial Vaginosis in Human Immunodeficiency Virus-Infected Women. J Clin Microbiol 2005;43:4607-4612. PMC1234056
150 Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, and Spear GT. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005;191:25-32.
149 Shiboski C, Cohen M, Weber K, Shansky A, Malvin K, and Greenblatt R. Factors associated with use of dental services among HIV-infected and high-risk uninfected women. J Am Dent Assoc 2005:136(9):1242-1255.
148 Spear GT, Alves ME, Cohen MH, Bremer J, and Landay AL. Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals. FEMS Immunol Med Microbiol 2005;45:129-136.
147 Strickler H, Burk R, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine A, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, and Palefsky J. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005;97:577-586.
146 Watts DH, Fazarri M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine A, Burk R, Palefsky J, Moxley M, Ahdieh-Grant L, and Strickler H. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1- uninfected women. J Infect Dis 2005;191:1129-1139.
145 Zariffard M, Novak R, Lurain N, Sha B, Graham P, and Spear G. Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 2005;191 (11):1913-1921.
144 Zariffard M, Sha B, Wang Q, Chen H, Bremer J, Cohen M, and Spear G. Relationship of U1 cell HIV- stimulatory activity to bacterial vaginosis and HIV genital tract virus load. AIDS Res Hum Retroviruses 2005;21(11):945-948.

2004 Publications (32)

143 Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, and Gange SJ. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 2004;96:1070-1076.
142 Anastos K, Barrón Y, Cohen MH, Greenblatt RM, Minkoff H, Levine A, Young M, and Gange SJ. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Ann Intern Med 2004;140:256-264.
141 Anastos K, Shi Q, French AL, Levine A, Greenblatt RM, Williams C, DeHovitz J, Delapenha R, and Hoover DR. Total Lymphocyte Count, Hemoglobin, and Delayed-Type Hypersensitivity as Predictors of Death and AIDS Illness in HIV-1-Infected Women Receiving Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr 2004;35:383-392.
140 Barrón Y, Cole SR, Greenblatt RM, Cohen MH, Anastos K, DeHovitz JA, Delapenha R, and Gange SJ. Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy. AIDS 2004;18:1579-1584.
139 Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, and Levine AM. Impact of Highly Active Antiretroviral Therapy on Anemia and Relationship Between Anemia and Survival in a Large Cohort of HIV-Infected Women: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2004;37:1245-1252.
138 Cohen MH, Cook JA, Grey D, Young M, Hanau LH, Tien P, Levine AM, and Wilson TE. Medically Eligible Women Who Do Not Use HAART: The Importance of Abuse, Drug Use, and Race. Am J Public Health 2004;94:1147-1151. PMC1448413
137 Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, Wilson TE, Young MA, and Hessol NA. Depressive Symptoms and AIDS-Related Mortality Among a Multisite Cohort of HIV- Positive Women. Am J Public Health 2004;94:1133-1140. PMC1448411
136 French AL, Benning L, Anastos K, Augenbraun M, Nowicki M, Sathasivam K, and Terrault NA. Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection. Clin Infect Dis 2004;39:402-410.
135 Glesby MJ, Hoover DR, Tan T, Shi Q, Gao W, French AL, Maurer T, Young M, DeHovitz J, Ru J, and Anastos K. Herpes Zoster in Women With and at Risk for HIV: Data From the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2004;37:1604-1609.
134 Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves ME, Macphail LA, Mulligan R, and Greenspan JS. Incidence of Oral Lesions in HIV-1-infected Women: Reduction with HAART. J Dent Res 2004;83:145-150.
133 Hessol N, Seaberg EC, Preston-Martin S, Massad LS, Sacks H, Silver S, Melnick S, Abulafia O, Levine A, and WIHS Collaborative Study Group. Cancer Risk Among Participants in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2004;36:978-985.
132 Hessol N, Gandhi M, and Greenblatt R. Epidemiology and natural history of HIV infection in women. Editor: Anderson J. HIV/AIDS Bureau, Health Resources and Services Administration, US Department of Health and Human Services, Washington, DC, 2004.
131 Kobayashi A, Greenblatt RM, Anastos K, Minkoff H, Massad LS, Young M, Levine AM, Darragh TM, Weinberg V, and Smith-McCune KK. Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection. Cancer Res 2004;64:6766-6774.
130 Kuo WH, Wilson TE, Weber KM, Madhava V, Richardson J, Delapenha R, and DesJarlais D.

Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the

Women’s Interagency HIV Study (WIHS). AIDS Patient Care STDS 2004;18:702-713.

129 Lurain NS, Robert ES, Xu J, Camarca M, Landay A, Kovacs AA, and Reichelderfer PS. HIV Type 1 and

Cytomegalovirus Coinfection in the Female Genital Tract. J Infect Dis 2004;190:619-623.

128 Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, Strickler HD, Levine AM, Sacks HS, Moxley M, and Watts DH. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 2004;190:1241-1248.
127 Massad LS, Schneider MF, Watts DH, Strickler HD, Melnick S, Palefsky J, Anastos K, Levine AM, and Minkoff H. HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance. J Womens Health 2004;13:147-153.
126 Massad LS, Seaberg EC, Watts H, Hessol N, Melnick S, Bitterman P, Anastos K, Silver S, Levine A, and Minkoff H. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program. AIDS 2004;18:109-113.
125 Massad LS, Evans CT, Minkoff H, Watts DH, Strickler HD, Darragh T, Levine A, Anastos K, Moxley M, and Passaro DJ. Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus. Obstet Gynecol 2004;104:1077-1085.
124 Massad LS, Springer G, Jacobson L, Watts H, Anastos K, Korn A, Cejtin H, Stek A, Young M, Schmidt J, and Minkoff H. Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS 2004;18:281-286.
123 Maurer T, Rodrigues LK, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, French AL, Glesby M, Jordan C, Khalsa A, and Hessol NA. The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. Clin Infect Dis 2004;38:579-584.
122 Minkoff H, Feldman JG, Strickler HD, Watts DH, Bacon MC, Levine A, Palefsky JM, Burk R, Cohen MH, and Anastos K. Relationship between smoking and human papillomavirus infections in HIV- infected and -uninfected women. J Infect Dis 2004;189:1821-1828.
121 Mulligan R, Phelan JA, Brunelle J, Redford M, Pogoda JM, Nelson E, Seirawan H, Greenspan JS, Navazesh M, Greenspan D, and Alves ME. Baseline characteristics of participants in the oral health component of the Women’s Interagency HIV Study. Community Dent Oral Epidemiol 2004;32:86-98.
120 Nag P, Kim J, Sapiega V, Landay AL, Bremer JW, Mestecky J, Reichelderfer P, Kovacs A, Cohn J, Weiser B, and Baum LL. Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis 2004;190:1970-1978.
119 Palacio H, Li X, Wilson TE, Sacks H, Cohen MH, Richardson J, Young M, and Muñoz A. Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivety. AIDS 2004;18:621-630.
118 Phelan JA, Mulligan R, Nelson E, Brunelle J, Alves ME, Navazesh M, and Greenspan D. Dental caries in HIV-seropositive women. J Dent Res 2004;83:869-873.
117 Philpott S, Burger H, Tarwater PM, Lu M, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young M, Miotti P, Dupuis M, and Weiser B. CCR2 genotype and disease progression in a treated population of HIV type 1-infected women. Clin Infect Dis 2004;39:861-865.
116 Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, and Gange SJ. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women’s Interagency HIV Study. Clin Infect Dis 2004;39:717-724.
115 Szczech LA, Hoover DR, Feldman JG, Cohen MH, Gange SJ, Gooze L, Rubin NR, Young MA, Cai X, Shi Q, Gao W, and Anastos K. Association between renal disease and outcomes among HIV- infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004;39:1199-1206.
114 Tien PC, Kovacs A, Bacchetti P, French AL, Augenbraun M, Cole SR, Hessol N, and Justman J. Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B virus infection in the Women’s Interagency HIV Study. Clin Infect Dis 2004;39:1363-1370.
113 Wilson TE, Gore ME, Greenblatt R, Cohen M, Minkoff H, Silver S, Robison E, Levine A, and Gange SJ. Changes in Sexual Behavior Among HIV-Infected Women After Initiation of HAART. Am J Public Health 2004;94:1141-1146. PMC1448412
112 Zariffard MR, Harwani S, Novak RM, Graham PJ, Ji X, and Spear GT. Trichomonas vaginalis infection activates cells through toll-like receptor 4. Clin Immunol 2004;111:103-107.

2003 Publications (18)

111 Augenbraun M, Goedert JJ, Thomas D, Feldman J, Seaberg EC, French AL, Robison E, Nowicki M, and Terrault N. Incident hepatitis C virus in women with human immunodeficiency virus infection. Clin Infect Dis 2003;37:1357-1364.
110 Burke JK, Cook JA, Cohen MH, Wilson T, Anastos K, Young M, Palacio H, Richardson J, and Gange S. Dissatisfaction with medical care among women with HIV: dimensions and associated factors. AIDS Care 2003;15:451-462.
109 Cejtin HE. Gynecologic issues in the HIV-infected woman. Obstet Gynecol Clin North Am 2003;30(4):711-729.
108 Cejtin HE, Jacobson L, Springer G, Watts DH, Levine A, Greenblatt R, Anastos K, Minkoff HL, Massad LS, and Schmidt JB. Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women. AIDS 2003;17:1702-1704.
107 Cole SR, Hernan MA, Robins JM, Anastos K, Chmiel J, Detels R, Ervin C, Feldman J, Greenblatt R, Kingsley L, Lai S, Young M, Cohen M, and Muñoz A. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol 2003;158:687-694.
106 Cook J, Boxer A, Burke J, Cohen M, Weber K, Shekarloo P, Lubin H, and Mock L. Child care arrangements of children orphaned by HIV/AIDS: the importance of grandparents as kinship caregivers. J of HIV/AIDS & Social Services 2003;2(2):5-20.
105 Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, Williams C, Goldwasser P, and Anastos K. Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr 2003;33:66-73.
104 Harlow SD, Cohen M, Ohmit SE, Schuman P, Cu-Uvin S, Lin X, Greenblatt R, Gurtman A, Khalsa A, Minkoff H, Young MA, and Klein RS. Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus. Am J Obstet Gynecol 2003;188:881-886.
103 Justman JE, Benning L, Danoff A, Minkoff H, Levine A, Greenblatt RM, Weber K, Piessens E, Robison E, and Anastos K. Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr 2003;32:298-302.
102 Kemal KS, Foley B, Burger H, Anastos K, Minkoff H, Kitchen C, Philpott SM, Gao W, Robison E, Holman S, Dehner C, Beck S, Meyer WA, III, Landay A, Kovacs A, Bremer J, and Weiser B. HIV-1 in genital tract and plasma of women: Compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc Natl Acad Sci USA 2003;12972-12977. PMC240729
101 Landay A, Benning L, Bremer J, Weiser B, Burger H, Nowicki M, and Kovacs A. Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high- risk HIV-seronegative women who use illicit drugs. J Infect Dis 2003;188:209-218.
100 Mirmirani P, Hessol NA, Maurer TA, Berger TG, Greenblatt RM, and Price VH. Hair changes in women from the Women’s Interagency HIV Study. Arch Dermatol 2003;139:105-106.
99 Navazesh M, Mulligan R, Barrón Y, Redford M, Greenspan D, Alves M, and Phelan J. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women’s Interagency HIV Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod

2003;95:693-698.

98 Philpott S, Weiser B, Tarwater P, Vermund SH, Kleeberger CA, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young MA, Miotti P, Dupuis M, Chen CH, and Burger H. CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. J Infect Dis 2003;187:569-575.
97 Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, and Burk RD. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003;95:1062-1071.
96 Tien PC, Cole SR, Williams CM, Li R, Justman JE, Cohen MH, Young M, Rubin N, Augenbraun M, and Grunfeld C. Incidence of lipoatrophy and lipohypertrophy in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2003;34:461-466.
95 Viscidi RP, Ahdieh-Grant L, Clayman B, Fox K, Massad LS, Cu-Uvin S, Shah KV, Anastos KM, Squires KE, Duerr A, Jamieson DJ, Burk RD, Klein RS, Minkoff H, Palefsky J, Strickler H, Schuman P, Piessens E, and Miotti P. Serum immunoglobulin G response to human papillomavirus type 16 virus- like particles in human immunodeficiency virus (HIV)-positive and risk- matched HIV-negative women. J Infect Dis 2003;187:194-205.
94 Viscidi RP, Ahdieh-Grant L, Schneider MF, Clayman B, Massad LS, Anastos KM, Burk RD, Minkoff H, Palefsky J, Levine A, and Strickler H. Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus-Like Particles in Human Immunodeficiency Virus (HIV)-Positive and High-Risk HIV- Negative Women. J Infect Dis 2003;188:1834-1844.

2002 Publications (19)

93 Al Harthi L, Guilbert LJ, Hoxie JA, and Landay A. Trophoblasts are productively infected by CD4- independent isolate of HIV type 1. AIDS Res Hum Retroviruses 2002;18:13-17.
92 Al Harthi L and Landay A. Immune recovery in HIV disease: role of the thymus and T cell expansion in immune reconstitution strategies. J Hematother Stem Cell Res 2002;11:777-786.
91 Anastos K, Barrón Y, Miotti P, Weiser B, Young M, Hessol N, Greenblatt RM, Cohen M, Augenbraun M, Levine A, and Muñoz A. Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease. Arch Intern Med 2002;162:1973-1980.
90 Battle-Miller K, Eby CA, Landay AL, Cohen MH, Sha BE, and Baum LL. Antibody-dependent cell- mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1-infected women. J Infect Dis 2002;185:439-447.
89 Cohen MH, French AL, Benning L, Kovacs A, Anastos K, Young M, Minkoff H, and Hessol NA. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002;113:91-98.
88 Cook JA, Cohen MH, Burke J, Grey D, Anastos K, Kirstein L, Palacio H, Richardson J, Wilson T, and Young M. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr 2002;30:401-409.
87 Cook JA, Cohen MH, Grey D, Kirstein L, Burke J, Anastos K, Palacio H, Richardson J, Wilson TE, and Young M. Use of highly active antiretroviral therapy in a cohort of HIV- seropositive women. Am J Public Health 2002;92:82-87. PMC1447394
86 Falusi O, French AL, Seaberg EC, Tien PC, Watts DH, Minkoff H, Piessens E, Kovacs A, Anastos K, and Cohen MH. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin Infect Dis 2002;35:1414-1417.
85 French AL, Cohen MH, Gange SJ, Burger H, Gao W, Semba RD, Meyer WA, III, Robison E, and

Anastos K. Vitamin A deficiency and genital viral burden in women infected with HIV-1. Lancet

2002;359:1210-1212.

84 Gange SJ, Barrón Y, Greenblatt RM, Anastos K, Minkoff H, Young M, Kovacs A, Cohen M, Meyer WA, III, and Muñoz A. Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J Epidemiol Community Health 2002;56:153-159.
83 Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, and Gange SJ. Prevalence and correlates of highly active antiretroviral therapy switching in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2002;29:495-503.
82 Kobayashi A, Darragh T, Herndier B, Anastos K, Minkoff H, Cohen M, Young M, Levine A, Ahdieh- Grant L, Hyun W, Weinberg V, Greenblatt R, and Smith-McCune K. Lymphoid Follicles Are Generated in High-Grade Cervical Dysplasia and Have Differing Characteristics Depending on HIV Status. Am J Pathol 2002;160:151-164. PMC1867118
81 Macphail LA, Komaroff E, Alves ME, Navazesh M, Phelan JA, and Redford M. Differences in risk factors among clinical types of oral candidiasis in the Women’s Interagency HIV Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:45-55.
80 Preston-Martin S, Kirstein LM, Pogoda JM, Rimer B, Melnick S, Masri-Lavine L, Silver S, Hessol N, French AL, Feldman J, Sacks HS, Deely M, and Levine AM. Use of mammographic screening by HIV-infected women in the Women’s Interagency HIV Study (WIHS). Prev Med 2002;34:386-392.
79 Richardson JL, Martin EM, Jimenez N, Danley K, Cohen M, Carson VL, Sinclair B, Racenstein JM, Reed RA, and Levine AM. Neuropsychological functioning in a cohort of HIV infected women: importance of antiretroviral therapy. J Int Neuropsychol Soc 2002;8:781-793.
78 Silverberg MJ, Ahdieh-Grant L, Muñoz A, Anastos K, Burk R, Cu-Uvin S, Duerr A, Greenblatt R, Klein R, Massad LS, Minkoff H, Muderspach L, Palefsky J, Piessens E, Schuman P, Watts H, and Shah K. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis 2002;29:427-435.
77 Szczech LA, Gange SJ, Van Der HC, Bartlett JA, Young M, Cohen MH, Anastos K, Klassen PS, and Svetkey LP. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002;61:195-202.
76 Wilson TE, Barrón Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, and Young M. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis 2002;34:529-534.
75 Zariffard MR, Saifuddin M, Sha BE, and Spear GT. Detection of bacterial vaginosis-related organisms by real-time PCR for Lactobacilli, Gardnerella vaginalis and Mycoplasma hominis. FEMS Immunol Med Microbiol 2002;34:277-281.

2001 Publications (26)

74 Abu-Rustum NR, Lee S, and Massad LS. Screening for HIV infection in indigent women with newly diagnosed cervical cancer. J Acquir Immune Defic Syndr 2001;27:95-96.
73 Ahdieh-Grant L, Silverberg MJ, Palacio H, Minkoff H, Anastos K, Young MA, Nowicki M, Kovacs A, Cohen M, and Muñoz A. Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels. AIDS 2001;15:2101-2108.
72 Al Harthi L, Kovacs A, Coombs RW, Reichelderfer PS, Wright DJ, Cohen MH, Cohn J, Cu-Uvin S, Watts H, Lewis S, Beckner S, and Landay A. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS 2001;15:1535-1543.
71 Al Harthi L and Landay A. HIV in the female genital tract: viral shedding and mucosal immunity. Clin Obstet Gynecol 2001;44:144-153.
70 Augenbraun M, Corey L, Reichelderfer P, Wright DJ, Burns D, Koelle DM, Robison E, and Cohen M. Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women. Clin Infect Dis 2001;33:885-890.
69 Augenbraun M, Tarwater P, Greenblatt R, Cohen M, French A, Gore ME, Watts H, Preston-Martin S, and Anastos K. Opportunistic infection prophylaxis in the Women’s Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 2001;28:195-196.
68 Cohen M. Women Coping with HIV/AIDS. We take it as it is. Social Science & Medicine

2001;53:1557-1558.

67 Cohen MH. Women and HIV: creating an ambiance of caring. J Am Med Womens Assoc 2001;56:9-10.
66 Coombs RW, Wright DJ, Reichelderfer PS, Burns DN, Cohn J, Cu-Uvin S, Baron PA, Cohen MH, Landay AL, Lewis S, and Kovacs A. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis 2001;184:1187-1191.
65 Greenblatt RM, Jacobson LP, Levine AM, Melnick S, Anastos K, Cohen M, DeHovitz J, Young MA, Burns D, Miotti P, and Koelle DM. Human herpesvirus 8 infection and Kaposi’s sarcoma among human immunodeficiency virus-infected and -uninfected women. J Infect Dis 2001;183:1130-

1134.

64 Hashemi FB, Mollenhauer J, Madsen LD, Sha BE, Nacken W, Moyer MB, Sorg C, and Spear GT. Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication. AIDS 2001;15:1-9.
63 Hessol NA, Schwarcz S, Ameli N, Oliver G, and Greenblatt RM. Accuracy of self-reports of acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related conditions in women. Am J Epidemiol 2001;153:1128-1133.
62 Hessol NA, Schneider M, Greenblatt RM, Bacon M, Barranday Y, Holman S, Robison E, Williams C, Cohen M, and Weber K. Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy. Am J Epidemiol 2001;154:563-573.
61 Hilton JF, Alves M, Anastos K, Canchola AJ, Cohen M, Delapenha R, Greenspan D, Levine A, Macphail LA, Micci SJ, Mulligan R, Navazesh M, Phelan J, and Tsaknis P. Accuracy of diagnoses of HIV-related oral lesions by medical clinicians. Findings from the Women’s Interagency HIV Study. Community Dent Oral Epidemiol 2001;29:362-372.
60 Hogben M, Gange S, Watts DH, Robison E, Young M, Richardson J, Cohen M, and DeHovitz J. The Effect of Sexual and Physical Violence on Risky Sexual Behavior and STDs Among a Cohort of HIV Seropositive Women. AIDS and Behavior 2001;5:353-361.
59 Kovacs A, Wasserman SS, Burns D, Wright DJ, Cohn J, Landay A, Weber K, Cohen M, Levine A, Minkoff H, Miotti P, Palefsky J, Young M, and Reichelderfer P. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001;358:1593-1601.
58 Levine AM, Berhane K, Masri-Lavine L, Sanchez M, Young M, Augenbraun M, Cohen M, Anastos K, Newman M, Gange SJ, and Watts H. Prevalence and correlates of anemia in a large cohort of HIV- infected women: Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2001;26:28-35.
57 Massad LS, Schneider M, Watts DH, Darragh T, Abulafia O, Salzer E, Muderspach L, Sidaway M, and Melnick S. Correlating Papanicolaou Smear, Colposcopic Impression, and Biopsy Among Women with HIV-1: Results from the WIHS. J Lower Genital Tract Dis 2001;5:212-218.
56 Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, Miotti P, Anastos K, Moxley M, Muderspach LI, and Melnick S. Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr 2001;27:432-442.
55 Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, Muderspach L, Burk R, and Palefsky J. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001;15:2157-2164.
54 Mirmirani P, Hessol NA, Maurer TA, Berger TG, Nguyen P, Khalsa A, Gurtman A, Micci S, Young M, Holman S, Gange SJ, and Greenblatt RM. Prevalence and predictors of skin disease in the Women’s Interagency HIV Study (WIHS). J Am Acad Dermatol 2001;44:785-788.
53 Nowicki MJ, Benning L, Bremer JW, Meyer WA, III, Hanson C, Brambilla D, Silver S, and Kovacs A. Longitudinal variability of human immunodeficiency virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and NucliSens assays in a large multicenter study. J Clin Microbiol 2001;39:3760-3763. PMC88428
52 Richardson J, Barkan S, Cohen M, Back S, FitzGerald G, Feldman J, Young M, and Palacio H. Experience and covariates of depressive symptoms among a cohort of HIV infected women. Soc Work Health Care 2001;32:93-111.
51 Schuman P, Ohmit S, Cohen M, Sacks H, Richardson J, Young M, Schoenbaum E, Rompalo A, and Gardner L. Prescription of and Adherence to Antiretroviral Therapy Among Women with AIDS. AIDS and Behavior 2001;5:371-378.
50 Simoes JA, Hashemi FB, Aroutcheva AA, Heimler I, Spear GT, Shott S, and Faro S. Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics. J Infect Dis 2001;184:22-27.
49 Steffens CM, Smith KY, Landay A, Shott S, Truckenbrod A, Russert M, and Al Harthi L. T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV- infected and HIV-uninfected individuals. AIDS 2001;15:1757-1764.

2000 Publications (22)

48 Ahdieh L, Gange SJ, Greenblatt R, Minkoff H, Anastos K, Young M, Nowicki M, Kovacs A, Cohen M, and Muñoz A. Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus. Am J Epidemiol 2000;152:923-933.
47 Al Harthi L, Wright DJ, Anderson D, Cohen M, Matity AD, Cohn J, Cu-Uvin S, Burns D, Reichelderfer P, Lewis S, Beckner S, Kovacs A, and Landay A. The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon Cytokine Res 2000;20:719-724.
46 Anastos K, Gange SJ, Lau B, Weiser B, Detels R, Giorgi JV, Margolick JB, Cohen M, Phair J, Melnick S, Rinaldo CR, Kovacs A, Levine A, Landesman S, Young M, Muñoz A, and Greenblatt RM. Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr 2000;24:218-226.
45 Baron P, Bremer J, Wasserman SS, Nowicki M, Driscoll B, Polsky B, Kovacs A, and Reichelderfer PS. Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol

2000;38:3822-3824. PMC87482

44 Bremer J, Nowicki M, Beckner S, Brambilla D, Cronin M, Herman S, Kovacs A, and Reichelderfer P. Comparison of two amplification technologies for detection and quantitation of human immunodeficiency virus type 1 RNA in the female genital tract. Division of AIDS Treatment Research Initiative 009 Study Team. J Clin Microbiol 2000;38:2665-2669. PMC86993
43 Cohen M, Deamant C, Barkan S, Richardson J, Young M, Holman S, Anastos K, Cohen J, and Melnick S. Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV. Am J Public Health 2000;90:560-565. PMC1446192
42 Cu-Uvin S, Wright DJ, Anderson D, Kovacs A, Watts DH, Cohn J, Landay A, and Reichelderfer PS. Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle. Women’s Health Study (WHS) 001 and WHS 001a Study Team. J Womens Health Gend Based Med 2000;9:857-863.
41 DeHovitz JA, Kovacs A, Feldman JG, Anastos K, Young M, Cohen M, Gange SJ, Melnick S, and Greenblatt RM. The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women’s Interagency HIV Study. J Infect Dis 2000;182:1527-1530.
40 Feldman JG, Burns DN, Gange SJ, Bacchetti P, Cohen M, Anastos K, Nowicki M, Delapenha R, and Miotti P. Serum albumin as a predictor of survival in HIV-infected women in the Women’s Interagency HIV Study. AIDS 2000;14:863-870.
39 French AL, Kirstein LM, Massad LS, Semba RD, Minkoff H, Landesman S, Palefsky J, Young M, Anastos K, and Cohen MH. Association of vitamin A deficiency with cervical squamous intraepithelial lesions in human immunodeficiency virus-infected women. J Infect Dis 2000;182:1084-1089.
38 Greenblatt RM and Hessol NA. Epidemiology and natural history of HIV infection in women. In: Guide to Clinical Management of Women with HIV. Editor: Anderson J. HIV/AIDS Bureau, Health Resources and Services Administration, US Department of Health and Human Services, Washington, DC, 2000;Chapter 1:1-33.
37 Greenspan D, Komaroff E, Redford M, Phelan JA, Navazesh M, Alves ME, Kamrath H, Mulligan R, Barr CE, and Greenspan JS. Oral mucosal lesions and HIV viral load in the Women’s Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 2000;25:44-50.
36 Harlow SD, Schuman P, Cohen M, Ohmit SE, Cu-Uvin S, Lin X, Anastos K, Burns D, Greenblatt R, Minkoff H, Muderspach L, Rompalo A, Warren D, Young MA, and Klein RS. Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr 2000;24:68-75
35 Hashemi FB, Spear GT, Madsen L, and Mollenhauer J. Detection and molecular mass determination of an HIV replication- enhancing female genital tract factor using a blot bioassay. Biotechniques 2000;28:478,480,482,484.
34 Hashemi FB, Ghassemi M, Faro S, Aroutcheva A, and Spear GT. Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J Infect Dis 2000;181:1574-1580.
33 Hessol NA, Anastos K, Levine AM, Ameli N, Cohen M, Young M, Augenbraun M, Miotti P, and Gange SJ. Factors associated with incident self-reported AIDS among women enrolled in the Women’s Interagency HIV Study (WIHS). WIHS Collaboratorive Study Group. AIDS Res Hum Retroviruses 2000;16:1105-1111.
32 Massad LS, Kirstein L, Darragh T, Bitterman P, Sidaway M, Muderspach L, Abulafia O, Salzer E, Watts H, and Melnick S. Interrater variability in diagnosis of cervical biopsies from women with HIV-1: results from the Women’s Interagency HIV Study. J Lower Genital Tract Dis 2000;4:190-194.
31 Mulligan R, Navazesh M, Komaroff E, Greenspan D, Redford M, Alves M, and Phelan J. Salivary gland disease in human immunodeficiency virus-positive women from the WIHS study. Women’s Interagency HIV Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:702-709.
30 Reichelderfer PS, Coombs RW, Wright DJ, Cohn J, Burns DN, Cu-Uvin S, Baron PA, Coheng MH, Landay AL, Beckner SK, Lewis SR, and Kovacs AA. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team. AIDS 2000;14:2101-2107.
29 Steffens CM, Al Harthi L, Shott S, Yogev R, and Landay A. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naive phenotypes. Clin Immunol 2000;97:95-101.
28 Swanson B, Hershow RC, Sha BE, Benson CA, Cohen M, and Gunfeld C. Body composition in HIV- infected women. Nutrition 2000;16:1064-1068.
27 Whitman S, Murphy J, Cohen M, and Sherer R. Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997. Arch Intern Med 2000;160:365-369.

1999 Publications (14)

26 Al Harthi L, Roebuck KA, Olinger GG, Landay A, Sha BE, Hashemi FB, and Spear GT. Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr 1999;21:194-202.
25 Anastos K, Kalish LA, Palacio H, Benson CA, Delapenha R, Chirgwin K, Stonis L, and Telzak EE. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women’s Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 1999;21:141-147.
24 Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, Delapenha R, DeHovitz J, Cohen M, Meyer W, Bremer J, and Kovacs A. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the Women’s Interagency HIV Study. AIDS 1999;13:1717-1726.
23 Cejtin HE, Komaroff E, Massad LS, Korn A, Schmidt JB, Eisenberger-Matiyahu D, and Stier E. Adherence to colposcopy among women with HIV infection. J Acquir Immune Defic Syndr 1999;22:247-252.
22 Greenblatt RM, Bacchetti P, Barkan S, Augenbraun M, Silver S, Delapenha R, Garcia P, Mathur U, Miotti P, and Burns D. Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women’s Interagency HIV Study (WIHS). Sex Transm Dis 1999;26:143-151.
21 Hashemi FB, Ghassemi M, Roebuck KA, and Spear GT. Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis. J Infect Dis 1999;179:924-930.
20 Massad LS, Ahuja J, and Bitterman P. Case Report: Verrucous carcinoma of the vulva in a patient infected with the human immunodeficiency virus. Gynecol Oncol 1999;73:315-318.
19 Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Burns D, Greenblatt RM, Muderspach LI, and Miotti P. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women’s Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999;21:33-41.
18 Massad LS, Furumoto-Dawson A A, Garcia PM, Bitterman P, Sha BE, and Cohen M. Yield of screening colposcopy among human immunodeficiency virus-infected women. J Lower Genital Tract Dis 1999;3:185-190.
17 Olinger GG, Hashemi FB, Sha BE, and Spear GT. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. AIDS 1999;13:1905-1912.
16 Palacio H, Shiboski CH, Yelin EH, Hessol NA, and Greenblatt RM. Access to and utilization of primary care services among HIV-infected women. J Acquir Immune Defic Syndr 1999;21:293-300.
15 Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, and Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)- positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-236.
14 Patterson BK, Czerniewski M, Andersson J, Sullivan Y, Su F, Jiyamapa D, Burki Z, and Landay A. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin Immunol 1999;91:254-262.
13 Wilson TE, Massad LS, Riester KA, Barkan S, Richardson J, Young M, Gurtman A, and Greenblatt R. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women’s Interagency HIV Study. AIDS 1999;13:591-598.

1998 Publications (8)

12 Al Harthi L, Spear GT, Hashemi FB, Landay A, Sha BE, and Roebuck KA. A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis 1998;178:1343-1351.
11 Barkan SE, Melnick SL, Preston-Martin S, Weber K, Kalish LA, Miotti P, Young M, Greenblatt R, Sacks H, and Feldman J. The Women’s Interagency HIV Study. WIHS Collaborative Study Group. Epidemiol 1998;9:117-125.
10 Hershow RC, Kalish LA, Sha B, Till M, and Cohen M. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis 1998;25:527-532.
9 Hessol NA. The changing epidemiology of HIV-related cancers. The AIDS Reader 1998;8:45-49.
8 Patterson BK, Landay A, Andersson J, Brown C, Behbahani H, Jiyamapa D, Burki Z, Stanislawski D, Czerniewski MA, and Garcia P. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol 1998;153:481-490. PMC1852974
7 Spear GT, Sha BE, Saarloos MN, Benson CA, Rydman R, Massad LS, Gilmore R, and Landay AL. Chemokines are present in the genital tract of HIV-seropositive and HIV- seronegative women: correlation with other immune mediators. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:454-459.
6 Stern RA, Arruda JE, Somerville JA, Cohen RA, Boland RJ, Stein MD, and Martin EM. Neurobehavioral functioning in asymptomatic HIV-1 infected women. J Int Neuropsychol Soc 1998;4:172-178.
5 Telzak EE, Hershow R, Kalish LA, Hardy WD, Jr., Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, and Anastos K. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV- infected women and women at risk for HIV infection. Women’s Interagency HIV Study. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:513-518.

1997 Publications (2)

4 Sha BE, D’Amico RD, Landay AL, Spear GT, Massad LS, Rydman RJ, Warner NA, Padnick J, Ackatz L, Charles LA, and Benson CA. Evaluation of immunologic markers in cervicovaginal fluid of HIV- infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:161-168.
3 Spear GT, Al Harthi L, Sha B, Saarloos MN, Hayden M, Massad LS, Benson C, Roebuck KA, Glick NR, and Landay A. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS 1997;11:1319-1326.

1996 Publications (1)

2 Hessol NA and Palacio H. Gender, ethnicity and transmission category variation in HIV disease progression. AIDS 1996;S69-S74.

1995 Publications (1)

1 Massad LS, Farhi MS, Ackatz L, Sha B, and Benson C. Sexual behavior of heterosexual women infected with HIV. J Womens Health Gend Based Med 1995;4:681-684.

Pin It on Pinterest